Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3026285	s-antitry	g/l (g/l)	5114	5501	0.04%
3026285	s-antitry	— (—)	576	607	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of liver

2293

1132

23.27

307.65

1.1

1.56

1.47

g/l

8.75

2046

1034

Oesophageal varices

360

167

27.63

307.65

1.2

1.1

1.62

1.53

g/l

1.71

334

153

GASTRO-related operations

1184

1294

4.66

307.65

1.1

1.0

1.50

1.40

g/l

10.16

1077

1176

Alcoholic liver disease

561

288

22.35

307.65

1.1

1.69

1.52

g/l

6.86

492

262

Nonalcoholic fatty liver disease

797

433

22.60

307.65

1.1

1.43

1.48

g/l

2.00

714

387

Chronic hepatitis, not elsewhere classified

238

33.91

307.65

1.2

1.1

1.57

1.47

g/l

1.62

214

Other diseases of liver

1248

547

26.75

307.65

1.1

1.48

g/l

0.09

1100

504

Fibrosis and cirrhosis of liver

692

208

42.72

307.65

1.2

1.0

1.63

1.52

g/l

3.05

630

190

Any gastric operation

1184

1294

4.66

307.65

1.1

1.0

1.50

1.40

g/l

10.16

1077

1176

Abnormal serum enzyme levels

741

1422

5.31

307.65

1.1

1.47

1.55

g/l

5.33

688

1276

Abnormal findings on examination of blood, without diagnosis

985

2131

4.38

307.65

1.1

1.49

1.54

g/l

2.97

913

1910

Ascites

370

269

15.46

307.65

1.2

1.1

1.71

1.50

g/l

9.32

340

246

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

298

220

15.13

307.65

1.3

1.1

1.66

1.53

g/l

3.50

281

186

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1021

557

21.72

307.65

1.2

1.1

1.66

1.50

g/l

12.64

923

504

Cirrhosis of liver, NAS

550

188

39.80

307.65

1.2

1.1

1.65

1.51

g/l

4.28

505

174

Hepatocellular carcinoma, including Hilmo

212

26.78

295.13

1.4

1.1

1.63

1.57

g/l

0.56

204

ILD medications

1717

3342

2.83

286.02

1.1

1.52

1.48

g/l

2.88

1588

2998

ILD medications: prednisolone, methylprednisolone, prednisone

1623

3283

2.81

269.70

1.1

1.52

1.48

g/l

2.30

1492

2944

First line medication for Crohn's disease

1652

3242

2.79

269.38

1.1

1.52

1.48

g/l

3.48

1528

2904

Hepatic failure, not elsewhere classified

199

23.90

269.15

1.2

1.1

1.68

1.46

g/l

4.87

182

Inflammatory bowel disease treatment related agents

1711

3570

2.72

268.68

1.1

1.51

1.49

g/l

1.09

1583

3207

Cholangitis (primary sclerosing, PSC)

264

226

12.89

263.20

1.2

1.1

1.62

1.47

g/l

4.29

248

197

Other inflammatory liver diseases

240

191

13.70

249.83

1.1

1.60

1.48

g/l

2.55

222

174

Asthma, excluding more controls

1166

1879

3.29

244.96

1.1

1.45

1.48

g/l

1.78

1073

1691

ILD medications: immunosuppressive drugs

1028

3057

3.18

244.89

1.2

1.1

1.53

1.48

g/l

3.30

965

2746

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

215

148

16.18

244.12

1.3

1.0

1.69

1.54

g/l

2.85

205

126

Asthma

1187

1995

3.17

236.17

1.1

1.45

1.50

g/l

2.55

1090

1801

Gastrointestinal diseases

761

867

4.46

233.55

1.1

1.0

1.50

1.42

g/l

4.66

682

805

Asthma (only as main-diagnosis), excluding more controls

1067

1879

3.30

233.13

1.1

1.44

1.48

g/l

2.61

980

1691

Oral corticosteroids

1526

3470

2.64

231.98

1.1

1.51

1.50

g/l

0.83

1399

3115

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1036

3064

3.09

231.72

1.1

1.50

1.53

g/l

1.36

941

2758

Malignant neoplasm of liver and intrahepatic bile ducts

169

24.11

228.41

1.3

1.0

1.66

1.58

g/l

0.76

161

Asthma (only as main-diagnosis)

1077

1995

3.17

222.69

1.1

1.44

1.50

g/l

3.60

988

1801

Alcohol use disorder, Swedish definition

925

2772

3.12

212.37

1.1

1.64

1.48

g/l

21.60

814

2536

Disorders of gallbladder, biliary tract and pancreas

1414

3479

2.60

211.50

1.1

1.53

1.50

g/l

1.50

1291

3144

Chronic lower respiratory diseases

1681

3727

2.43

209.23

1.1

1.47

1.51

g/l

2.65

1541

3358

COPD

711

1603

3.71

206.74

1.1

1.54

1.56

g/l

0.57

649

1432

Abnormal results of function studies

290

401

7.75

200.29

1.1

1.46

1.50

g/l

0.80

241

359

937

2918

2.96

195.33

1.1

1.64

1.48

g/l

22.03

824

2666

967

2997

2.89

192.81

1.1

1.63

1.48

g/l

21.82

852

2734

Emphysema

235

264

9.55

192.73

1.1

1.51

1.56

g/l

0.74

219

237

Hepatocellular carcinoma

139

25.19

190.02

1.3

1.0

1.64

1.58

g/l

0.50

134

Diseases of oesophagus, stomach and duodenum

1458

3644

2.42

186.47

1.1

1.53

1.49

g/l

3.35

1320

3307

Asthma (mode)

1073

2026

2.87

183.96

1.1

1.45

1.50

g/l

3.07

991

1826

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1354

3898

2.43

180.54

1.1

1.59

1.48

g/l

14.63

1239

3524

Early onset COPD, excluding more controls

383

771

5.12

178.65

1.1

1.53

g/l

0.06

348

689

Asthma, unspecified (mode), excluding more controls

746

1727

3.28

177.05

1.1

1.45

1.49

g/l

1.12

683

1555

Autoimmune diseases related-to ILD

1188

4149

2.48

174.98

1.1

1.53

1.49

g/l

2.07

1094

3745

Heart failure, not strict

1057

2710

2.69

172.61

1.1

1.63

1.48

g/l

19.93

972

2433

Autoimmune diseases excluding thyroid diseases

1415

3303

2.36

167.59

1.1

1.53

1.48

g/l

3.79

1298

2990

Autoimmune diseases excluding thyroid diseases, strict definition

1387

3225

2.38

167.17

1.1

1.53

1.48

g/l

3.88

1270

2919

Transplanted organ and tissue status

285

469

6.45

166.75

1.4

1.1

1.57

1.47

g/l

2.71

275

422

Cholangitis (primary sclerosing, PSC), with reimbursement 202

135

20.40

166.65

1.2

1.1

1.56

1.44

g/l

2.00

125

Asthma, unspecified (mode)

751

1830

3.14

166.10

1.1

1.46

1.50

g/l

1.61

687

1654

Abnormalities of breathing

1224

2894

2.49

164.21

1.1

1.48

1.50

g/l

0.69

1114

2617

Anaemias

410

534

5.13

164.13

1.1

1.63

1.39

g/l

16.92

374

493

Other diseases of biliary tract

227

301

7.97

162.17

1.2

1.1

1.63

1.51

g/l

3.29

215

270

L04AD Calcineurin inhibitors

304

565

5.69

156.58

1.3

1.1

1.55

1.49

g/l

1.63

294

504

Asthma-related infections

828

2991

2.75

154.74

1.1

1.48

1.51

g/l

1.38

762

2694

Asthma, hospital admission 2, infections

828

2991

2.75

154.74

1.1

1.48

1.51

g/l

1.38

762

2694

Asthma, hospital admissions , main diagnosis only

1124

4210

2.39

152.98

1.1

1.44

1.51

g/l

6.60

1034

3797

Asthma (diagnoses ohter than nonallergic)

1176

4210

2.35

152.19

1.1

1.45

1.51

g/l

4.87

1086

3796

Noninfective enteritis and colitis

737

2601

2.88

150.46

1.1

1.51

1.48

g/l

0.83

688

2349

Other chronic obstructive pulmonary disease

608

1540

3.32

150.41

1.1

1.56

g/l

0.08

547

1369

Inflammatory bowel disease

568

1759

3.31

146.45

1.1

1.50

1.49

g/l

0.30

534

1588

Primary biliary cholangitis (PBC)

118

19.77

146.40

1.1

1.52

1.48

g/l

0.40

104

Tramadol

1075

2696

2.48

145.85

1.1

1.55

1.47

g/l

6.75

978

2444

Hernia of abdominal wall, postoperative

251

414

6.20

145.14

1.1

1.51

1.43

g/l

1.90

227

375

COPD (mode)

446

917

3.90

138.01

1.1

1.57

1.53

g/l

0.93

401

821

5-aminosalicylic acid

394

1002

4.04

136.82

1.1

1.49

1.48

g/l

0.04

367

899

IBD patients in KELA-register

448

1252

3.68

135.93

1.1

1.49

g/l

0.05

420

1129

Asthma, including avohilmo

1491

4040

2.09

133.88

1.1

1.45

1.52

g/l

8.39

1368

3642

Any reimbursement code in KELA

725

1221

3.01

131.73

1.1

1.49

1.41

g/l

4.24

670

1085

Inflammatory bowel disease, strict (require KELA)

448

1279

3.60

131.64

1.1

1.49

g/l

0.13

420

1159

Symptoms and signs involving the digestive system and abdomen

1249

2812

2.25

129.19

1.1

1.53

1.48

g/l

3.41

1129

2553

ILD medications: azathioprine

293

626

4.84

127.78

1.1

1.55

1.48

g/l

1.74

278

558

Dyspnoea

1145

3851

2.22

127.50

1.1

1.49

1.51

g/l

0.68

1053

3481

Autoimmune diseases

1378

3324

2.13

125.73

1.1

1.51

1.48

g/l

1.66

1261

3009

Azathioprine

293

640

4.73

124.39

1.1

1.55

1.49

g/l

1.61

278

569

Colitis, primary sclerosing

103

19.40

123.98

1.2

1.0

1.56

1.39

g/l

2.46

COPD, early/later onset

611

1794

2.92

123.03

1.1

1.56

1.54

g/l

0.26

550

1602

COPD, hospital admissions

608

1787

2.93

122.99

1.1

1.56

1.54

g/l

0.25

548

1594

Budesonide

272

574

4.90

120.44

1.1

1.53

1.49

g/l

0.81

249

512

629

2280

2.78

120.34

1.1

1.46

1.50

g/l

1.78

581

2057

Asthma/COPD (KELA code 203)

1164

3721

2.17

119.98

1.1

1.45

1.51

g/l

4.57

1064

3352

Other chronic obstructive pulmonary disease, including avohilmo

702

2204

2.67

119.43

1.1

1.54

g/l

0.02

635

1992

Implicit Sepsis

944

3082

2.34

118.97

1.1

1.61

1.48

g/l

14.97

847

2783

Examination and observation for other reasons

768

1695

2.65

117.31

1.1

1.50

1.51

g/l

0.31

712

1548

Implicit bacterial Sepsis

538

1601

3.03

117.12

1.1

1.66

1.49

g/l

12.52

490

1429

COPD, hospital admissions 1, only main diagnosis

472

1253

3.29

116.53

1.1

1.56

1.55

g/l

0.02

423

1119

Unspecified jaundice

143

162

9.39

116.43

1.1

1.0

1.69

1.49

g/l

5.18

133

150

Ulcerative colitis

433

1308

3.39

116.42

1.1

1.49

1.50

g/l

0.16

405

1180

Implicit Sepsis

1016

3357

2.24

114.82

1.1

1.60

1.48

g/l

14.89

913

3029

Asthma-related pneumonia or sepsis

493

1619

3.09

114.46

1.1

1.51

1.53

g/l

0.56

454

1449

Asthma, hospital admissions 3, pneumonia

493

1619

3.09

114.46

1.1

1.51

1.53

g/l

0.56

454

1449

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

639

1435

2.85

114.31

1.2

1.1

1.57

1.43

g/l

10.41

596

1297

Asthma-related pneumonia

491

1619

3.08

113.21

1.1

1.51

1.53

g/l

0.54

452

1449

Bacterial Sepsis

601

1859

2.81

113.14

1.1

1.66

1.50

g/l

13.26

551

1670

Implicit bacterial Sepsis

574

1754

2.87

113.00

1.1

1.66

1.49

g/l

12.90

525

1571

Cholelithiasis, broad definition with cholecystitis

1029

3145

2.23

112.74

1.1

1.51

g/l

0.02

946

2836

Condition for Implicit Sepsis (Organ dysfunction codes)

1057

3454

2.18

111.77

1.1

1.60

1.47

g/l

15.96

951

3118

Early onset COPD

383

1099

3.58

111.77

1.1

1.53

1.52

g/l

0.18

348

995

Other bacterial diseases

1255

3910

2.06

111.19

1.1

1.60

1.46

g/l

22.69

1163

3519

Non-allergic asthma (mode), excluding more controls

294

694

4.29

111.02

1.1

1.46

1.50

g/l

0.86

272

619

Cholelithiasis

989

3095

2.23

109.12

1.1

1.50

1.51

g/l

0.13

907

2788

Acute renal failure

339

912

3.81

108.78

1.1

1.72

1.51

g/l

10.32

309

814

Renal failure

583

1884

2.78

108.68

1.1

1.68

1.51

g/l

12.63

534

1685

Other bacterial diseases

1170

3816

2.08

108.53

1.1

1.62

1.47

g/l

22.68

1083

3437

Used for control exclusion in common control thyroid runs

1266

3113

2.07

108.05

1.1

1.51

1.48

g/l

1.22

1158

2814

Abnormal findings on diagnostic imaging of lung

607

2206

2.68

107.30

1.1

1.52

1.54

g/l

0.66

564

1988

Condition for Implicit Sepsis (Organ dysfunction codes)

1098

3615

2.12

106.78

1.1

1.60

1.46

g/l

17.80

990

3272

Non-allergic asthma (mode)

294

715

4.16

106.72

1.1

1.46

1.50

g/l

1.10

272

639

Malignant neoplasm of digestive organs

522

1420

2.95

105.53

1.2

1.1

1.67

1.51

g/l

10.15

492

1267

Fever of other and unknown origin

718

2627

2.46

105.47

1.1

1.60

1.49

g/l

10.00

676

2368

General symptoms and signs

1308

3260

2.03

105.16

1.1

1.52

1.47

g/l

3.73

1189

2943

Dental caries

422

1278

3.24

104.85

1.2

1.1

1.58

1.50

g/l

2.51

384

1169

Type 2 diabetes, wide definition

950

2743

2.24

104.57

1.1

1.54

1.50

g/l

2.15

861

2478

L04AA Selective immunosuppressants

396

1214

3.35

104.17

1.2

1.1

1.56

1.50

g/l

1.90

375

1094

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

420

577

3.69

103.21

1.1

1.0

1.48

1.44

g/l

0.99

383

526

Symptoms and signs involving the circulatory and respiratory systems

1189

2902

2.07

101.03

1.1

1.49

1.50

g/l

0.34

1085

2625

Septicaemia

535

1839

2.76

100.03

1.1

1.65

1.49

g/l

12.17

495

1639

Mucosal proctocolitis

265

641

4.28

98.98

1.1

1.50

1.49

g/l

0.10

248

573

Other septicaemia

480

1618

2.90

98.75

1.1

1.67

1.49

g/l

11.88

446

1440

Diseases of the digestive system

595

2326

2.58

98.69

1.1

1.57

1.51

g/l

2.86

544

2092

Explicit Sepsis

547

1915

2.71

98.30

1.1

1.65

1.49

g/l

12.66

506

1714

Other gastritis (incl. Duodenitis)

331

944

3.59

97.34

1.1

1.59

1.51

g/l

2.15

295

848

Insulin medication

740

2678

2.35

97.10

1.1

1.60

1.50

g/l

7.50

665

2424

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

310

858

3.72

95.72

1.1

1.47

1.50

g/l

0.75

290

769

Iron deficiency anaemia

542

2036

2.66

95.41

1.1

1.64

1.51

g/l

9.43

488

1839

Crohn disease

261

642

4.20

95.31

1.1

1.51

1.50

g/l

0.21

248

574

Other diseases of intestines

1263

3707

1.95

94.96

1.1

1.52

1.49

g/l

1.59

1156

3371

Obesity related asthma

489

1782

2.80

94.57

1.1

1.45

1.53

g/l

3.81

448

1599

Ulcerative colitis, NAS

269

681

4.08

94.40

1.1

1.47

1.51

g/l

0.68

248

612

Ulcerative colitis (strict definition, require KELA)

314

887

3.64

94.01

1.1

1.47

1.50

g/l

0.64

293

795

Bacterial infection, other or unspecified

692

2487

2.38

93.47

1.1

1.65

1.49

g/l

14.50

645

2228

Nutritional anaemias

603

2353

2.50

93.24

1.1

1.63

1.51

g/l

9.35

544

2123

Medical observation and evaluation for suspected diseases and conditions

783

1701

2.38

92.63

1.1

1.48

1.51

g/l

0.83

695

1554

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

326

967

3.46

90.50

1.1

1.47

1.50

g/l

0.42

304

868

Caries of dentine

367

1136

3.21

90.06

1.2

1.1

1.58

1.50

g/l

2.53

331

1036

Other pulmonary diagnosis

886

2013

2.22

89.89

1.1

1.50

g/l

0.08

808

1818

Type 2 diabetes

1147

3419

1.98

89.78

1.1

1.52

1.49

g/l

1.57

1042

3093

Excluding asthma or asthma-COPD overlap

885

2013

2.22

89.55

1.1

1.50

g/l

0.10

807

1818

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

197

256

5.61

89.43

1.1

1.55

1.49

g/l

0.95

173

240

COPD related to multimorbidity

481

1480

2.79

89.40

1.1

1.58

1.55

g/l

0.57

433

1319

Second line medication for Crohn's disease

752

3425

2.22

89.30

1.1

1.52

1.49

g/l

1.63

704

3088

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1116

3414

1.99

89.25

1.1

1.53

1.49

g/l

2.48

1021

3088

Gastro-oesophageal reflux disease

798

3177

2.19

89.08

1.1

1.51

1.49

g/l

0.54

716

2887

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1049

3157

2.03

89.03

1.1

1.56

1.48

g/l

5.95

960

2854

1049

3157

2.03

89.03

1.1

1.56

1.48

g/l

5.95

960

2854

Bronchiectasis

157

268

6.11

88.34

1.1

1.47

1.56

g/l

1.45

147

240

Substance abuse, excluding more controls

722

2737

2.28

88.08

1.1

1.61

1.50

g/l

8.91

626

2504

Abdominal and pelvic pain

1116

2812

2.01

87.89

1.1

1.50

1.48

g/l

1.11

1018

2553

Bacterial infection, other or unspecified

633

2321

2.40

87.19

1.1

1.66

1.49

g/l

15.05

588

2078

Opioids

1126

2966

1.99

86.89

1.1

1.52

1.46

g/l

4.92

1035

2690

Diabetes, insulin treatment (Kela reimbursement)

1170

3698

1.93

85.91

1.1

1.53

1.49

g/l

2.50

1070

3335

Insulin, combination of fast acting with intermediate-acting or long-acting

740

3087

2.22

85.89

1.1

1.60

1.51

g/l

7.11

665

2798

COPD, hospital admission 2, with asthma infections

396

1140

3.03

85.70

1.1

1.60

1.55

g/l

1.13

358

1019

Diabetes, varying definitions

1175

3610

1.92

85.25

1.1

1.51

1.48

g/l

1.89

1066

3270

COPD differential diagnosis

875

2026

2.18

84.91

1.1

1.50

g/l

0.10

801

1826

ILD differential diagnosis

875

2026

2.18

84.90

1.1

1.50

g/l

0.10

801

1826

Influenza and pneumonia

1229

4194

1.88

84.56

1.1

1.56

1.47

g/l

7.67

1124

3794

Insulin, intermediate and long-acting

670

2893

2.28

84.09

1.1

1.60

1.51

g/l

6.01

603

2622

Bleeding

964

3423

2.02

84.08

1.1

1.57

1.51

g/l

4.13

870

3091

GI-bleeding

410

1448

2.88

84.06

1.1

1.60

1.53

g/l

2.28

376

1297

Metabolic disorders

1118

3545

1.94

83.98

1.1

1.52

1.50

g/l

0.84

1006

3213

Diabetes mellitus

1174

3621

1.91

83.42

1.1

1.51

1.48

g/l

1.89

1067

3280

Endocrine, nutritional and metabolic diseases

937

2281

2.10

82.81

1.1

1.48

1.47

g/l

0.42

855

2085

Dialysis, with operation codes

235

594

4.09

82.79

1.2

1.1

1.63

1.49

g/l

4.93

227

534

Pneumonias (Asthma/COPD co-morbidities)

1173

4215

1.88

82.41

1.1

1.57

1.48

g/l

8.95

1076

3816

Other diseases of the digestive system

410

1467

2.84

82.08

1.1

1.59

1.53

g/l

2.10

378

1312

Haemorrhage from respiratory passages

409

1306

2.86

81.40

1.1

1.57

1.54

g/l

0.71

371

1167

All pneumoniae

1176

4232

1.87

81.03

1.1

1.57

1.48

g/l

8.47

1079

3829

Cardiovascular diseases (excluding rheumatic etc)

773

2037

2.20

79.82

1.1

1.51

1.42

g/l

8.34

712

1854

Aplastic and other anaemias

527

2007

2.48

79.45

1.1

1.67

1.52

g/l

9.70

476

1811

Other diseases of pleura

527

1878

2.49

79.30

1.1

1.59

1.54

g/l

1.75

484

1678

Hypertensive diseases (excluding secondary)

650

1613

2.37

79.18

1.1

1.51

1.42

g/l

5.97

589

1461

Pneumonia, organism unspecified

1061

3920

1.91

78.90

1.1

1.58

1.48

g/l

8.87

969

3541

Other nutritional deficiencies

805

3711

2.06

78.41

1.1

1.51

1.49

g/l

0.33

718

3382

Type 2 diabetes, definitions combined

1068

3277

1.93

78.20

1.1

1.51

1.49

g/l

0.87

972

2960

Other and unspecified anaemias

490

1864

2.54

78.03

1.1

1.66

1.52

g/l

7.92

443

1681

Type 2 diabetes, definitions combined, including avohilmo

1075

3284

1.92

77.70

1.1

1.51

1.49

g/l

0.80

979

2969

Diabetes medication

1167

3752

1.86

76.65

1.1

1.52

1.48

g/l

2.04

1059

3401

Dipeptidyl peptidase 4 (DPP-4) inhibitors

617

2170

2.30

76.57

1.1

1.59

1.53

g/l

3.12

556

1958

Nephropathy related operations

229

602

3.94

76.46

1.2

1.1

1.64

1.51

g/l

3.51

221

541

Type 2 diabetes, strict (exclude DM1)

1067

3306

1.91

75.96

1.1

1.51

1.49

g/l

0.70

971

2988

Other anaemias

491

1890

2.50

75.82

1.1

1.65

1.52

g/l

8.11

444

1703

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1090

3737

1.88

75.82

1.1

1.56

1.50

g/l

5.07

994

3372

Cholecystectomy

806

3434

2.04

75.40

1.1

1.50

1.51

g/l

0.42

740

3086

Mental and behavioural disorders due to psychoactive substance use

742

3332

2.09

74.17

1.1

1.60

1.49

g/l

10.14

645

3049

All kidney diseases

1108

4129

1.85

73.82

1.1

1.58

1.48

g/l

10.73

1012

3734

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1130

4232

1.84

73.58

1.1

1.57

1.48

g/l

9.09

1036

3832

Substance abuse

722

3275

2.09

73.14

1.1

1.61

1.49

g/l

10.65

626

2999

Renal tubulo-interstitial diseases

969

3804

1.91

72.99

1.1

1.62

1.49

g/l

14.43

887

3432

Chronic hepatitis NAS

16.61

72.92

1.1

1.63

1.48

g/l

1.64

Certain infectious and parasitic diseases

1096

2925

1.89

72.74

1.1

1.53

1.45

g/l

7.01

1009

2634

Other disorders of fluid, electrolyte and acid-base balance

385

1346

2.77

72.68

1.1

1.66

1.52

g/l

6.66

341

1208

Pain in throat and chest

917

2810

1.98

72.36

1.1

1.49

1.50

g/l

0.26

838

2544

Chronic gastritis

317

1058

3.04

72.08

1.1

1.54

1.52

g/l

0.40

279

951

Nausea and vomiting

322

1061

3.02

71.83

1.1

1.54

1.48

g/l

1.40

296

965

Reimbursement for rheumatic diseases

686

3275

2.11

71.54

1.1

1.53

1.50

g/l

1.27

628

2953

Oxycodone

442

1597

2.54

69.57

1.1

1.71

1.51

g/l

12.64

404

1435

Asthma and opportunity respiratory infection

109

170

6.77

67.39

1.1

1.43

1.57

g/l

2.13

103

155

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1085

3929

1.81

67.20

1.1

1.55

1.49

g/l

4.53

1001

3545

Other (not insulin) diabetes medications

1060

3452

1.84

67.09

1.1

1.52

1.49

g/l

1.20

962

3122

Obesity and other hyperalimentation

744

3620

2.00

66.87

1.1

1.50

g/l

0.08

658

3304

Other and unspecified iron deficiency

403

1588

2.57

66.67

1.1

1.64

1.51

g/l

7.54

364

1425

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

259

806

3.29

66.61

1.1

1.64

1.51

g/l

4.18

244

709

Heart failure and antihypertensive medication

319

686

3.09

66.41

1.1

1.64

1.49

g/l

6.19

291

614

L04AX Other immunosuppressants

681

3352

2.05

66.21

1.1

1.53

1.49

g/l

1.51

638

3021

Ulcerative colitis (strict definition, all Crohn cases excluded)

241

722

3.42

66.01

1.1

1.48

1.50

g/l

0.40

224

646

Chronic kidney disease

340

1211

2.79

65.97

1.1

1.64

1.52

g/l

4.60

310

1078

Obesity

739

3610

2.00

65.96

1.1

1.50

g/l

0.10

653

3294

Cough

464

1849

2.40

65.73

1.1

1.48

1.51

g/l

0.57

434

1660

6-mercaptopurine

126

7.82

65.41

1.1

1.51

1.44

g/l

0.84

111

Gastroduodenal ulcer

295

1001

2.98

64.82

1.1

1.63

1.53

g/l

3.12

266

895

Other special examinations and investigations of persons without complaint or reported diagnosis

708

1701

2.12

64.81

1.1

1.50

1.51

g/l

0.25

650

1554

Infections, IBD-co-morbidities

226

438

3.75

64.77

1.1

1.62

1.50

g/l

3.07

201

407

Obesity due to excess calories

579

2715

2.16

64.19

1.1

1.50

1.49

g/l

0.25

518

2473

Benign neoplasm: Colon

584

2645

2.13

62.24

1.1

1.56

1.54

g/l

0.61

526

2378

Heart failure,strict

543

1722

2.25

62.13

1.1

1.66

1.50

g/l

12.80

503

1538

Benign neoplasm of colon, rectum, anus and anal canal

680

2948

2.02

62.00

1.1

1.55

1.53

g/l

0.76

608

2666

Other heart diseases

559

1652

2.23

61.70

1.1

1.54

1.42

g/l

8.27

516

1502

Codeine

979

2910

1.84

61.35

1.1

1.53

1.46

g/l

5.57

881

2638

Other interstitial pulmonary diseases

213

623

3.50

60.57

1.1

1.54

1.55

g/l

0.05

188

556

Implicit viral Sepsis

329

1231

2.71

60.54

1.1

1.58

1.49

g/l

2.74

299

1101

Cardiovascular diseases

690

1804

2.07

60.41

1.1

1.50

1.41

g/l

6.43

640

1639

Other respiratory diseases principally affecting the interstitium

237

743

3.26

60.23

1.1

1.56

1.55

g/l

0.25

210

664

Interstitial lung disease

213

626

3.48

60.12

1.1

1.54

1.55

g/l

0.09

188

559

Interstitial lung disease endpoints

213

626

3.48

60.12

1.1

1.54

1.55

g/l

0.09

188

559

Depression medications

346

605

2.91

59.89

1.1

1.46

1.38

g/l

2.69

314

556

Hypertension, essential

887

2692

1.88

59.89

1.1

1.52

1.47

g/l

2.74

803

2442

ILD, hospital admissions

211

618

3.50

59.89

1.1

1.54

1.55

g/l

0.07

186

554

Acute pancreatitis

254

838

3.09

59.16

1.1

1.59

1.50

g/l

2.26

224

759

Other Crohn's disease

143

321

4.63

59.11

1.1

1.48

1.45

g/l

0.43

136

288

Persons encountering health services in other circumstances, wide

1258

3845

1.70

58.97

1.1

1.51

1.50

g/l

0.54

1148

3470

Mental and behavioural disorders due to alcohol

610

2888

2.05

58.91

1.1

1.62

1.49

g/l

10.63

526

2650

Later onset COPD, excluding more controls

218

485

3.53

58.83

1.0

1.1

1.61

1.56

g/l

0.67

193

424

Other medical care

510

2102

2.21

58.71

1.1

1.68

1.50

g/l

12.39

460

1884

Mental and behavioural disorders due to alcohol, excluding acute intoxication

547

2601

2.12

57.77

1.1

1.63

1.50

g/l

8.93

468

2386

Biguanides

1012

3505

1.77

57.64

1.1

1.52

1.50

g/l

0.72

919

3169

Other antidepressants

1107

3273

1.74

57.35

1.1

1.51

1.50

g/l

0.30

1001

2982

Continuous positive airway pressure

226

584

3.31

56.78

1.1

1.54

1.45

g/l

2.44

192

545

Viral hepatitis, IBD co-morbidity

113

216

5.41

56.37

1.1

1.67

1.45

g/l

4.67

103

198

General examination and investigation of persons without complaint and reported diagnosis

662

1701

2.05

55.71

1.1

1.51

g/l

0.08

599

1554

Neoplasms

838

2383

1.88

55.48

1.1

1.50

1.46

g/l

2.47

780

2161

COPD-related respiratory insufficiency

167

442

3.87

55.18

1.1

1.59

1.55

g/l

0.44

148

398

Gastric ulcer

209

646

3.29

54.32

1.1

1.63

1.54

g/l

2.06

186

576

COPD/asthma related infections

1083

3159

1.73

54.06

1.1

1.53

1.48

g/l

2.41

980

2855

COPD/asthma/ILD related infections

1083

3159

1.73

54.06

1.1

1.53

1.48

g/l

2.41

980

2855

Alcohol use disorder, ICD-based

504

2410

2.12

53.25

1.1

1.63

1.50

g/l

7.96

431

2201

Sleep apnoea, including avohilmo

1072

3929

1.70

53.17

1.1

1.45

1.51

g/l

6.16

974

3549

Oedema, not elsewhere classified

357

1463

2.44

52.77

1.1

1.56

1.49

g/l

2.09

323

1306

Mood disorders, excluding more controls

998

3462

1.73

52.42

1.1

1.50

1.49

g/l

0.22

895

3155

Other disorders of skin and subcutaneous tissue

727

3504

1.86

52.08

1.1

1.57

1.51

g/l

3.56

656

3159

Anxiety disorders, excluding more controls

895

3307

1.77

51.89

1.1

1.49

1.48

g/l

0.18

805

3011

Malaise and fatigue

531

2082

2.07

51.12

1.1

1.58

1.49

g/l

4.10

488

1855

Sleep apnoea

1014

3882

1.70

50.95

1.1

1.46

1.51

g/l

4.47

918

3510

Any death

653

2440

1.94

50.68

1.1

1.74

1.49

g/l

26.32

581

2219

Hypertensive diseases

871

2768

1.79

50.43

1.1

1.52

1.47

g/l

2.87

792

2509

Diseases of the skin and subcutaneous tissue

1067

3167

1.70

50.42

1.1

1.51

1.48

g/l

1.53

967

2865

Hypertension

870

2765

1.79

50.33

1.1

1.52

1.47

g/l

2.88

791

2506

All chronic kidney diseases

564

2314

2.01

50.27

1.1

1.63

1.50

g/l

9.05

516

2075

Benign neoplasm of other and ill-defined parts of digestive system

235

823

2.91

49.38

1.1

1.53

g/l

0.05

214

736

Persons encountering health services in other circumstances

453

2141

2.13

48.63

1.1

1.55

1.50

g/l

1.91

424

1930

Other respiratory disorders and diseases

238

846

2.86

48.55

1.1

1.56

1.53

g/l

0.44

215

760

Other diseases of the respiratory system

238

846

2.86

48.55

1.1

1.56

1.53

g/l

0.44

215

760

Persons encountering health services for specific procedures and health care

1135

4180

1.64

48.55

1.1

1.56

1.47

g/l

8.10

1029

3787

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1153

3845

1.64

48.46

1.1

1.50

g/l

0.19

1056

3470

Complications of surgical and medical care, not elsewhere classified

1024

4228

1.67

48.40

1.1

1.54

1.50

g/l

3.49

924

3835

Glucagon-like peptide-1 (GLP-1) analogues

359

1558

2.34

48.38

1.1

1.52

1.49

g/l

0.64

327

1410

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

359

1558

2.34

48.38

1.1

1.52

1.49

g/l

0.64

327

1410

Heart failure, strict

572

2047

1.99

47.97

1.1

1.66

1.52

g/l

10.91

528

1829

COPD, hospital admissions 3, with asthma pneumonia sepsis

278

905

2.66

47.80

1.1

1.61

1.55

g/l

0.96

254

818

Iron deficiency anaemia secondary to blood loss (chronic)

204

676

3.07

47.30

1.1

1.66

1.51

g/l

4.72

183

607

Insulin, fast-acting

412

1910

2.18

47.14

1.1

1.59

1.49

g/l

4.24

376

1726

ILD, hospital admissions 1, main diag only

182

570

3.27

46.53

1.1

1.56

1.55

g/l

0.03

161

510

Other soft tissue disorders, not elsewhere classified

974

3416

1.68

45.91

1.1

1.51

1.50

g/l

0.36

865

3112

Constipation

916

3773

1.69

45.64

1.1

1.54

1.50

g/l

1.69

824

3422

1145

3669

1.62

45.61

1.1

1.51

1.50

g/l

0.42

1044

3316

Chronic pancreatitis

173

533

3.32

45.46

1.1

1.64

1.49

g/l

3.48

157

480

Viral Sepsis

229

830

2.80

45.06

1.1

1.60

1.49

g/l

3.14

207

742

Undetermined asthma, excluding more controls

161

479

3.42

44.57

1.1

1.39

1.51

g/l

3.61

148

425

All-cause Heart Failure

555

2020

1.96

44.52

1.1

1.66

1.52

g/l

10.33

513

1803

Implicit viral Sepsis

228

830

2.79

44.50

1.1

1.60

1.49

g/l

3.14

206

742

Other diseases of pancreas

127

326

4.01

44.00

1.1

1.54

1.50

g/l

0.53

112

290

Other diseases of blood and blood-forming organs, wide

276

1113

2.52

43.90

1.1

1.61

1.51

g/l

2.78

253

998

Acute pancreatitis (for exclusion)

254

988

2.62

43.57

1.1

1.59

1.51

g/l

1.94

224

895

Complications of procedures, not elsewhere classified

828

4056

1.70

43.51

1.1

1.53

1.50

g/l

1.87

752

3677

Undetermined asthma

161

489

3.35

43.15

1.1

1.39

1.52

g/l

4.24

148

437

Persons encountering health services for examination and investigation

638

1701

1.89

42.96

1.1

1.51

g/l

0.06

578

1554

Any mental disorder

1127

3534

1.61

42.91

1.1

1.52

1.49

g/l

1.87

1004

3221

ILD, hospital admission 2, with pulmonary infections

132

354

3.82

42.89

1.1

1.57

1.52

g/l

0.67

116

316

Ischemic heart diseases

866

3082

1.70

42.66

1.1

1.54

1.50

g/l

1.90

789

2776

Antihypertensive medication - note that there are other indications

636

1805

1.88

42.60

1.1

1.48

1.43

g/l

2.10

584

1632

Depression or dysthymia

715

2215

1.79

41.71

1.1

1.49

1.50

g/l

0.27

644

2015

Depression

1000

4225

1.61

41.42

1.1

1.50

1.49

g/l

0.07

898

3835

Diverticular disease of intestine

709

2568

1.78

41.28

1.1

1.53

1.52

g/l

0.17

638

2326

Mood [affective] disorders

1057

4324

1.59

41.23

1.1

1.50

g/l

0.01

951

3922

Neurotic, stress-related and somatoform disorders

944

4076

1.63

41.02

1.1

1.49

g/l

0.02

850

3702

Other noninfective gastroenteritis and colitis

285

1204

2.40

40.83

1.1

1.51

g/l

0.04

262

1078

139

400

3.57

40.82

1.1

1.75

1.56

g/l

4.28

116

364

Anxiety disorders

949

4092

1.63

40.78

1.1

1.49

g/l

0.02

854

3717

Insulin, fast-acting or short human

412

2021

2.06

40.73

1.1

1.59

1.50

g/l

3.79

376

1821

Crohn's disease NAS

116

296

4.05

40.61

1.1

1.52

1.48

g/l

0.50

111

266

Crohn disease (strict definition, require KELA, min 2 HDR)

120

314

3.95

40.59

1.1

1.50

1.47

g/l

0.40

113

284

Mood disorders

1056

4329

1.59

40.55

1.1

1.50

g/l

0.01

950

3927

Percutaneous Coronary Intervention

813

2951

1.70

40.38

1.1

1.52

1.51

g/l

0.31

742

2662

Intestinal infectious diseases

1163

4283

1.56

40.37

1.1

1.54

1.49

g/l

3.58

1065

3870

Diseases of arteries, arterioles and capillaries (FINNGEN)

254

680

2.62

40.31

1.1

1.60

1.45

g/l

6.08

226

614

Other ulcerative colitis

108

264

4.23

40.11

1.2

1.1

1.52

1.47

g/l

0.48

235

Crohn disease (strict definition, require KELA)

120

318

3.90

39.88

1.1

1.50

1.47

g/l

0.41

113

287

Polyarthropathies

715

2691

1.75

39.70

1.1

1.55

1.51

g/l

1.53

653

2447

Coronary revascularization (ANGIO or CABG)

810

2951

1.69

39.52

1.1

1.52

1.51

g/l

0.38

740

2662

Dermatitis and eczema

1113

4464

1.55

38.70

1.1

1.51

1.50

g/l

0.60

1023

4032

Diarrhoea and gastroenteritis of presumed infectious origin

1022

4289

1.58

38.61

1.1

1.52

1.49

g/l

2.00

932

3874

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

124

344

3.72

38.55

1.1

1.50

1.46

g/l

0.63

117

312

Emergency coronary revascularization (for ACS)

853

3157

1.65

38.12

1.1

1.53

1.52

g/l

0.30

780

2838

Pain in joint

591

2074

1.83

38.07

1.1

1.49

1.51

g/l

0.56

520

1885

Diseases of the respiratory system

600

1632

1.85

38.02

1.1

1.51

1.50

g/l

0.21

541

1470

Complications of medical and surgical care

732

4020

1.69

37.93

1.1

1.54

1.51

g/l

1.40

656

3641

Other viral hepatitis

120

330

3.76

37.83

1.1

1.69

1.44

g/l

6.88

109

303

Respiratory insufficiency

101

244

4.21

37.75

1.1

1.58

1.54

g/l

0.38

213

Covid-19 confirmed case

382

1877

2.06

37.69

1.1

1.54

1.52

g/l

0.40

347

1691

Exposure to unspecified factor

1003

4624

1.57

37.50

1.1

1.50

g/l

0.12

917

4183

Diarrhoea and gastroenteritis of presumed infectious origin

714

3825

1.69

37.47

1.1

1.53

1.49

g/l

2.41

667

3457

Hypothyroidism (congenital or acquired)

256

566

2.58

37.40

1.1

1.50

1.38

g/l

4.59

226

522

Coagulation defects, purpura and other haemorrhagic conditions

236

955

2.51

37.35

1.2

1.1

1.54

1.52

g/l

0.32

225

854

Other heart diseases, wide

951

3658

1.60

37.30

1.1

1.53

1.47

g/l

4.14

869

3313

Hyperkalaemia

186

4.76

37.26

1.1

1.69

1.53

g/l

2.16

170

Hypothyroidism and >3 levothyroxin purchases

253

560

2.58

36.96

1.1

1.50

1.38

g/l

4.16

224

516

Hypothyroidism, levothyroxine purchases

253

560

2.58

36.96

1.1

1.50

1.38

g/l

4.16

224

516

Disorders of mineral metabolism

123

349

3.61

36.90

1.1

1.59

1.49

g/l

1.35

114

308

Purpura and other haemorrhagic conditions

178

630

2.88

36.85

1.2

1.1

1.56

1.51

g/l

0.82

168

560

Malignant neoplasm, wide definition for exclusion

897

3267

1.62

36.76

1.1

1.55

1.48

g/l

5.17

835

2945

Cardiac arrhythmias

590

2135

1.81

36.75

1.1

1.51

1.45

g/l

2.85

539

1943

Other acute lower respiratory infections

534

2812

1.82

36.68

1.1

1.51

1.50

g/l

0.19

482

2548

Major coronary heart disease event

845

3129

1.64

36.62

1.1

1.54

1.51

g/l

1.12

769

2813

Hard cardiovascular diseases

857

3148

1.63

36.46

1.1

1.53

1.49

g/l

1.99

775

2842

Intestinal infectious diseases

941

4558

1.57

36.10

1.1

1.55

1.49

g/l

3.89

876

4109

Pain (limb, back, neck, head abdominally)

729

2138

1.72

36.03

1.1

1.50

1.51

g/l

0.17

663

1945

Benign neoplasms

982

3444

1.58

35.91

1.1

1.50

g/l

0.13

897

3129

Viral hepatitis

128

384

3.43

35.34

1.1

1.67

1.45

g/l

5.94

117

349

Allergic asthma (mode), excluding more controls

237

962

2.44

35.29

1.1

1.43

1.47

g/l

1.20

224

864

Crohn's disease of small intestine

118

337

3.60

35.14

1.1

1.53

1.47

g/l

0.79

112

305

Neurological diseases, wide definition

326

729

2.26

35.01

1.1

1.45

1.47

g/l

0.29

297

683

Atrial fibrillation and flutter

316

930

2.22

34.93

1.1

1.54

1.44

g/l

4.02

295

838

Bronchitis

1048

4322

1.53

34.71

1.1

1.51

1.50

g/l

0.61

943

3922

Crohn's disease of large intestine

236

4.16

34.59

1.1

1.56

1.48

g/l

1.19

213

Sleep disorders (combined)

1108

3828

1.53

34.50

1.1

1.48

1.51

g/l

1.50

1000

3466

Erysipelas

685

3129

1.68

34.26

1.1

1.58

1.48

g/l

8.38

627

2800

Alcohol dependence

302

1411

2.17

34.17

1.1

1.64

1.50

g/l

6.63

256

1293

Non-invasive ventilation

221

799

2.49

34.03

1.1

1.58

1.45

g/l

4.03

193

743

Factors influencing health status and contact with health services

302

661

2.31

34.00

1.1

1.0

1.49

g/l

0.00

273

597

Irritable bowel syndrome

291

1343

2.19

33.93

1.1

1.45

1.49

g/l

1.22

259

1206

Allergic asthma (mode)

237

981

2.39

33.83

1.1

1.43

1.48

g/l

1.61

224

887

Codeine or tramadol medication

1112

4046

1.51

33.35

1.1

1.53

1.49

g/l

2.53

998

3669

Other symptoms and signs involving the digestive system and abdomen

180

676

2.70

33.22

1.1

1.50

g/l

0.09

155

610

Abnormalities of heart beat

324

1541

2.08

33.00

1.1

1.47

1.50

g/l

0.57

295

1383

Certain infectious and parasitic diseases

714

2138

1.68

32.76

1.1

1.53

1.46

g/l

4.11

643

1929

Thrombocytopenia, unspecified

109

312

3.59

32.37

1.2

1.1

1.58

1.52

g/l

0.64

103

284

Acute bronchitis

399

2060

1.91

32.18

1.1

1.50

1.51

g/l

0.24

361

1859

Acute upper respiratory infections

1006

4090

1.52

32.06

1.1

1.49

1.51

g/l

0.50

919

3690

Hypo-osmolality and hyponatraemia

177

670

2.66

31.79

1.1

1.66

1.53

g/l

2.79

155

589

Abnormal findings on diagnostic imaging of other body structures

161

585

2.80

31.78

1.1

1.52

g/l

0.08

153

525

Implicit fungal Sepsis

234

3.99

31.54

1.1

1.51

1.49

g/l

0.21

207

Gout

273

1104

2.20

31.45

1.1

1.62

1.55

g/l

1.28

250

992

Atrial fibrillation and flutter with reimbursement

244

658

2.38

31.43

1.1

1.56

1.45

g/l

3.38

231

591

Anxiety (asthma-related co-morbidities)

620

2864

1.69

31.40

1.1

1.48

1.47

g/l

0.51

557

2624

Dermatitis

595

3541

1.69

31.38

1.1

1.53

1.51

g/l

1.01

548

3194

Follow-up examination after treatment for conditions other than malignant neoplasms

402

1384

1.94

31.16

1.1

1.50

g/l

0.10

366

1254

Functional dyspepsia

267

1233

2.19

31.14

1.1

1.49

g/l

0.01

242

1109

Cholecystitis

147

521

2.86

30.36

1.1

1.60

1.51

g/l

1.18

136

468

Episodal and paroxysmal disorders

1071

3659

1.50

30.28

1.1

1.46

1.51

g/l

3.79

967

3303

Heart failure and coronary heart disease

376

1376

1.95

30.26

1.1

1.68

1.54

g/l

6.68

349

1218

Colorectal adenocarcinoma

188

754

2.52

30.20

1.1

1.61

1.53

g/l

1.64

178

661

Hypokalaemia

140

487

2.92

29.99

1.1

1.69

1.51

g/l

4.07

122

436

Finngen Rheumatological endpoints

958

3605

1.52

29.78

1.1

1.51

1.49

g/l

0.91

862

3271

Fungal Sepsis

156

4.65

29.39

1.1

1.53

1.50

g/l

0.17

141

Biological medication for rheuma

216

939

2.34

29.30

1.1

1.46

1.49

g/l

0.53

200

853

Other metabolic disorders

159

599

2.70

29.29

1.2

1.1

1.13

1.49

g/l

11.57

137

542

Later onset COPD

228

792

2.32

29.18

1.0

1.1

1.60

1.57

g/l

0.36

202

701

ILD-related respiratory insufficiency

116

5.30

28.75

1.1

1.60

1.57

g/l

0.20

106

Certain disorders involving the immune mechanism

224

997

2.28

28.74

1.1

1.53

1.51

g/l

0.32

213

902

Other and unspecified polyneuropathies, also in other diseases

204

873

2.37

28.68

1.1

1.54

1.53

g/l

0.10

185

784

Other diseases of intestine

159

606

2.66

28.62

1.1

1.56

1.52

g/l

0.52

148

535

Colorectal cancer

217

932

2.30

28.53

1.1

1.61

1.53

g/l

2.13

205

817

Implicit fungal Sepsis

144

4.75

28.46

1.1

1.51

1.50

g/l

0.08

130

Polyneuropathies and other disorders of the peripheral nervous system

230

1039

2.24

28.45

1.1

1.57

1.53

g/l

0.65

208

934

Substance use, excluding alcohol

233

1060

2.23

28.33

1.1

1.55

1.46

g/l

2.54

206

968

Neurological diseases

854

2783

1.55

28.30

1.1

1.47

1.51

g/l

1.81

775

2523

Gout, FINNGEN

273

1317

2.09

28.27

1.1

1.62

1.54

g/l

1.63

250

1178

Soft tissue disorders

999

3456

1.49

28.26

1.1

1.50

g/l

0.12

902

3147

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

574

3448

1.65

28.19

1.1

1.55

1.51

g/l

1.23

519

3115

Erysipelas

506

2624

1.72

28.17

1.1

1.59

1.49

g/l

6.40

458

2354

Selective serotonin reuptake inhibitors

946

3286

1.51

28.13

1.1

1.48

1.50

g/l

0.84

837

2994

Recurrent or chronic depression

425

1650

1.82

27.91

1.1

1.49

1.48

g/l

0.18

381

1503

Other functional intestinal disorders

412

2126

1.81

27.77

1.1

1.52

1.50

g/l

0.44

373

1919

Missing teeth due to accident, extraction or parodontitis

556

3176

1.66

27.55

1.1

1.58

1.52

g/l

2.35

487

2871

Other disorders of skin and subcutaneous tissue, not elsewhere classified

163

642

2.58

27.48

1.0

1.1

1.62

1.53

g/l

1.91

143

576

Malignant neoplasm

822

3179

1.54

27.31

1.1

1.56

1.48

g/l

5.73

766

2864

ILD, hospital admissions 3, with pneumonia sepsis

103

318

3.31

27.17

1.1

1.63

1.53

g/l

1.19

291

Benzodiazepine use

957

4477

1.48

27.15

1.1

1.54

1.49

g/l

2.39

839

4081

Unspecified kidney failure

112

364

3.13

27.09

1.1

1.64

1.51

g/l

2.09

103

331

Asthma and allergy, excluding more controls

142

518

2.74

27.05

1.1

1.41

1.47

g/l

1.16

137

466

Pain in limb

761

3296

1.55

27.04

1.1

1.52

1.50

g/l

0.32

677

3005

Falls/tendency to fall

1067

3677

1.46

26.66

1.1

1.49

g/l

0.01

953

3367

Acute sinusitis

525

2927

1.67

26.65

1.1

1.48

1.49

g/l

0.36

489

2645

Other and unspecified dermatitis

490

2909

1.70

26.59

1.1

1.53

1.50

g/l

0.76

452

2618

Psychiatric diseases

959

3238

1.49

26.57

1.1

1.51

1.49

g/l

1.12

861

2952

Acute peritonitis

274

3.48

26.50

1.2

1.1

1.63

1.54

g/l

0.96

251

Fall on same level

1115

4245

1.44

26.47

1.1

1.52

1.49

g/l

1.82

989

3879

Asthma and allergy

142

525

2.70

26.36

1.1

1.41

1.48

g/l

1.39

137

476

Any event in cancer register

885

3489

1.50

26.28

1.1

1.55

1.48

g/l

4.69

827

3147

All anxiety disorders

625

3098

1.60

26.27

1.1

1.48

g/l

0.19

561

2819

Smoking dependency

125

441

2.90

26.26

1.1

1.52

1.50

g/l

0.22

108

398

Pleural effusion

156

615

2.57

26.25

1.1

1.65

1.53

g/l

2.47

143

548

Headache

598

2966

1.62

26.21

1.1

1.45

1.47

g/l

0.45

536

2673

Systemic connective tissue disorders

328

1739

1.90

26.17

1.1

1.55

1.51

g/l

0.90

301

1568

Solid cancers, helper endpoint

805

3123

1.53

26.14

1.1

1.55

1.48

g/l

5.11

749

2813

Mental and behavioural disorders due to tobacco

125

444

2.88

25.94

1.1

1.52

1.50

g/l

0.24

108

399

Collagenous colitis

115

390

3.01

25.91

1.1

1.49

1.50

g/l

0.16

107

350

Low back pain

724

3371

1.55

25.90

1.1

1.46

1.50

g/l

2.03

647

3070

Disorders of thyroid, IBD co-morbidities

176

500

2.50

25.85

1.1

1.48

g/l

0.00

162

462

Noninfectious colitis NAS

155

615

2.56

25.77

1.1

1.55

1.50

g/l

0.76

140

543

Acute upper respiratory infections of multiple and unspecified sites

718

3458

1.55

25.60

1.1

1.50

g/l

0.18

649

3129

Hypothyroidism, strict autoimmune

626

2582

1.60

25.46

1.1

1.49

g/l

0.21

559

2326

Colectomy operation

179

765

2.37

25.32

1.1

1.52

1.54

g/l

0.40

172

680

Chronic sinusitis

424

2452

1.74

25.30

1.1

1.43

1.52

g/l

4.92

381

2236

Chronic laryngitis and laryngotracheitis

162

664

2.48

25.16

1.1

1.49

1.54

g/l

1.15

137

595

Gout, strict definition

184

798

2.34

25.16

1.1

1.67

1.54

g/l

2.80

169

713

Pain, not elsewhere classified

268

1345

2.01

25.15

1.1

1.52

1.47

g/l

0.80

244

1204

Tumor necrosis factor alpha inhibitors

189

832

2.31

24.99

1.1

1.44

1.49

g/l

0.87

173

752

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

529

3255

1.63

24.88

1.1

1.55

1.51

g/l

1.34

477

2946

Other diseases of stomach and duodenum

218

3.70

24.82

1.1

1.55

1.52

g/l

0.39

198

Non-ischemic cardiomyopathy

273

1100

2.02

24.81

1.1

1.60

1.51

g/l

2.94

251

968

Diseases of peritoneum

121

434

2.84

24.62

1.2

1.1

1.61

1.52

g/l

0.99

111

392

Malignant neoplasm of colon

140

542

2.62

24.47

1.1

1.60

1.55

g/l

0.81

134

479

Gout, idiopatic and unspecified

234

1132

2.09

24.36

1.1

1.63

1.54

g/l

1.88

214

1016

Vocal cord dysfunction

128

421

2.76

24.28

1.1

1.47

1.44

g/l

0.33

117

388

Dorsalgia

943

3469

1.46

24.23

1.1

1.48

1.50

g/l

0.72

848

3161

Parasetamol

747

2473

1.54

24.12

1.1

1.51

1.48

g/l

1.26

690

2234

Diagnoses used for exclusion with ILD

248

1230

2.04

24.11

1.1

1.57

1.52

g/l

1.04

230

1105

Disorders of lipoprotein metabolism and other lipidaemias

741

3026

1.52

23.96

1.1

1.53

1.51

g/l

0.81

678

2734

Malignant neoplasm of colon, including Hilmo

170

728

2.36

23.86

1.2

1.1

1.58

1.54

g/l

0.66

160

641

Valvular heart disease excluding rheumatic fever

423

1771

1.74

23.75

1.1

1.58

1.51

g/l

2.49

381

1596

Pulmonary heart disease, diseases of pulmonary circulation

287

1506

1.92

23.67

1.1

1.54

1.53

g/l

0.11

268

1349

Codes for special purposes

495

3040

1.64

23.47

1.1

1.53

1.50

g/l

0.89

444

2760

Other bacterial intestinal infections

182

811

2.27

23.36

1.1

1.66

1.52

g/l

3.64

166

726

Provisional assignment of new diseases of uncertain etiology

494

3039

1.63

23.27

1.1

1.53

1.50

g/l

0.84

443

2760

Diaphragmatic hernia

331

1832

1.82

23.11

1.1

1.54

1.53

g/l

0.17

299

1660

Bacterial intestinal infections, IBD co-morbidities

185

835

2.24

23.03

1.1

1.66

1.52

g/l

3.57

168

753

Non-rheumatic valve diseases

417

1755

1.73

22.95

1.1

1.58

1.51

g/l

2.31

375

1581

Chronic rhinitis, nasopharyngitis and pharyngitis

324

1786

1.83

22.94

1.1

1.44

1.51

g/l

2.50

286

1623

Other specific joint derangements/joint disorders

710

3033

1.52

22.92

1.1

1.48

1.49

g/l

0.30

628

2764

Symptoms and signs concerning food and fluid intake

116

424

2.77

22.70

1.1

1.55

1.49

g/l

0.67

105

372

Mycoses

270

1410

1.93

22.68

1.1

1.55

1.51

g/l

0.84

242

1264

Other reaction to severe stress, and adjustment disorders

368

2115

1.75

22.61

1.1

1.50

1.47

g/l

0.79

338

1928

Colon adenocarcinoma

115

420

2.78

22.61

1.2

1.1

1.58

1.54

g/l

0.45

110

367

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

267

3.28

22.54

1.0

1.1

1.68

1.55

g/l

1.59

236

Cerebrovascular diseases (FINNGEN)

277

1012

1.95

22.48

1.1

1.53

1.45

g/l

2.61

249

915

Myalgia

239

1202

2.01

22.40

1.1

1.48

1.50

g/l

0.22

208

1088

Paralytic ileus and intestinal obstruction

229

1136

2.03

22.24

1.1

1.56

1.52

g/l

0.80

204

1012

Use of hypnotics and sedatives

1002

4075

1.42

22.17

1.1

1.52

1.50

g/l

1.19

896

3703

Fibromyalgia

107

381

2.86

22.11

1.1

1.46

1.49

g/l

0.40

349

Gout, unspecified

194

908

2.16

22.09

1.1

1.64

1.54

g/l

1.91

176

812

Nerve, nerve root and plexus disorders

977

4233

1.42

22.06

1.1

1.50

1.51

g/l

0.49

877

3833

Other skin changes

184

844

2.21

22.06

1.1

1.51

1.53

g/l

0.39

169

748

Hypothyroidism, drug reimbursement

128

339

2.69

21.92

1.1

1.46

1.38

g/l

1.33

120

311

Childhood asthma (age<16), excluding more controls

134

412

2.59

21.87

1.1

1.42

1.43

g/l

0.08

123

372

Streptococcal septicaemia

102

357

2.91

21.77

1.2

1.1

1.63

1.50

g/l

1.89

316

Explicit bacterial Sepsis

114

423

2.74

21.76

1.1

1.62

1.48

g/l

2.85

106

374

Symptoms and signs involving the skin and subcutaneous tissue

642

4171

1.51

21.74

1.1

1.51

1.50

g/l

0.09

596

3758

Intracranial trauma

544

2421

1.59

21.68

1.1

1.49

1.51

g/l

0.44

485

2202

Heart failure and bmi 25plus

325

1209

1.83

21.52

1.1

1.65

1.52

g/l

5.79

304

1073

Childhood asthma (age<16)

134

416

2.56

21.48

1.1

1.42

1.44

g/l

0.13

123

377

Non-allergic asthma

108

393

2.80

21.43

1.1

1.43

1.52

g/l

1.63

100

351

Lower back pain or/and sciatica

968

4498

1.41

21.41

1.1

1.48

1.51

g/l

0.96

869

4081

Intestinal stricture

283

1530

1.87

21.38

1.2

1.1

1.56

1.53

g/l

0.63

255

1375

Other CVD (FINNGEN)

105

283

2.91

21.26

1.1

1.58

1.49

g/l

1.05

251

Chronic apical periodontitis

1034

4227

1.40

21.20

1.1

1.51

1.49

g/l

0.93

910

3851

Ulcer of lower limb, not elsewhere classified

143

600

2.42

21.16

1.1

1.66

1.54

g/l

2.94

128

535

Other diseases of upper respiratory tract

1003

3722

1.41

21.16

1.1

1.47

1.52

g/l

3.52

901

3381

Chronic viral hepatitis

269

3.21

21.04

1.1

1.70

1.43

g/l

5.92

244

Other bacterial intestinal infections

218

1087

2.03

20.97

1.1

1.64

1.51

g/l

3.66

199

966

Ischaemic heart disease, wide definition

700

2909

1.50

20.96

1.1

1.58

1.51

g/l

4.15

633

2621

Other disorders of urethra and urinary system

609

2889

1.53

20.67

1.1

1.51

1.50

g/l

0.12

548

2601

Other external causes of accidental injury

771

2630

1.47

20.50

1.1

1.50

1.49

g/l

0.24

697

2402

Obesity, other/unspecified

330

1897

1.75

20.34

1.1

1.49

g/l

0.16

293

1732

Other systemic involvement of connective tissue (FG)

238

1225

1.93

20.08

1.1

1.55

1.50

g/l

0.97

219

1102

Abnormal weight loss

105

391

2.73

20.00

1.1

1.54

1.52

g/l

0.17

353

Candidiasis

274

1503

1.84

19.82

1.1

1.51

1.50

g/l

0.04

245

1351

Hernia

863

4098

1.42

19.72

1.1

1.50

g/l

0.09

771

3714

Coronary atherosclerosis

558

2293

1.55

19.57

1.1

1.59

1.52

g/l

2.87

509

2052

Hernia of abdominal wall

418

2585

1.63

19.55

1.1

1.50

1.53

g/l

0.97

378

2340

Other diseases of anus and rectum

255

1371

1.87

19.49

1.1

1.53

1.51

g/l

0.31

240

1230

Injuries to the thorax

406

2493

1.64

19.48

1.1

1.58

1.52

g/l

1.97

365

2250

Pure hypercholesterolaemia

636

2780

1.50

19.44

1.1

1.54

1.51

g/l

0.76

579

2510

Combinations of oral blood glucose lowering drugs

248

1328

1.88

19.38

1.1

1.55

1.52

g/l

0.59

232

1195

Adalimumab

123

503

2.49

19.37

1.1

1.44

1.48

g/l

0.51

112

450

Other systemic involvement of connective tissue

247

1327

1.88

19.11

1.1

1.54

1.51

g/l

0.48

227

1187

Benign neoplasm: Transverse colon

119

483

2.51

19.04

1.2

1.1

1.61

1.55

g/l

0.73

111

432

Other or unspecified ileus, impaction or obstruction

163

757

2.17

18.97

1.2

1.1

1.57

1.52

g/l

0.88

147

668

Other dorsopathies, not elsewhere classified

929

3485

1.40

18.96

1.1

1.47

1.50

g/l

1.29

840

3173

Accidents

760

2630

1.45

18.84

1.1

1.51

1.49

g/l

0.43

689

2402

Weight loss

108

421

2.61

18.79

1.1

1.54

1.52

g/l

0.19

377

Duodenal ulcer

101

383

2.67

18.54

1.1

1.64

1.52

g/l

1.67

342

Diseases of arteries, arterioles and capillaries

554

2704

1.52

18.49

1.1

1.60

1.53

g/l

3.73

495

2462

Agranulocytosis

123

514

2.43

18.48

1.1

1.62

1.51

g/l

2.22

114

461

Dysphagia

196

986

2.00

18.44

1.1

1.51

1.50

g/l

0.05

176

891

305

1616

1.74

18.23

1.1

1.51

1.56

g/l

1.51

280

1430

Benign neoplasm: Colon, unspecified

225

1195

1.90

18.09

1.2

1.1

1.57

1.54

g/l

0.47

194

1068

Dorsopathies

948

3498

1.38

17.87

1.1

1.48

1.50

g/l

0.58

856

3186

Disorders of lens

608

2561

1.49

17.84

1.1

1.56

1.52

g/l

1.90

539

2341

Infections of the skin and subcutaneous tissue

543

3605

1.50

17.73

1.1

1.54

1.49

g/l

2.24

495

3268

Actinic keratosis

275

1442

1.78

17.68

1.1

1.50

1.57

g/l

2.37

254

1270

Other anxiety disorders

434

2398

1.58

17.53

1.1

1.47

g/l

0.04

390

2185

Candidiasis

138

623

2.24

17.34

1.0

1.1

1.51

g/l

0.02

120

562

Genitourinary diseases

575

1918

1.51

17.28

1.1

1.51

1.49

g/l

0.83

528

1742

Syncope and collapse

359

1879

1.64

17.21

1.1

1.57

1.50

g/l

2.14

329

1674

Osteoporosis

213

1052

1.91

17.20

1.1

1.60

1.54

g/l

0.95

189

938

Congenital malformations, deformations and chromosomal abnormalities

546

3509

1.49

17.16

1.1

1.48

g/l

0.15

505

3178

Viral pneumonia

130

576

2.28

17.09

1.1

1.51

g/l

0.07

120

520

Skin changes due to chronic exposure to nonionizing radiation

282

1500

1.74

17.03

1.1

1.50

1.56

g/l

2.01

260

1327

Problems related to lifestyle

118

504

2.37

16.91

1.1

1.59

1.51

g/l

1.38

100

456

Osteopathies and chondropathies

486

2998

1.52

16.72

1.1

1.56

1.51

g/l

1.86

434

2705

Vascular disorders of the intestines

232

3.07

16.55

1.0

1.1

1.62

1.54

g/l

0.77

206

Concussion

450

2391

1.54

16.43

1.1

1.47

1.51

g/l

1.02

408

2176

Paroxysmal tachycardia

187

799

1.97

16.40

1.1

1.60

1.44

g/l

4.17

168

716

Sarcoidosis

142

665

2.16

16.34

1.1

1.53

1.51

g/l

0.37

135

599

Volume depletion

350

2.63

16.31

1.1

1.83

1.52

g/l

6.05

310

Ulcerative rectosigmoiditis

100

405

2.51

16.16

1.1

1.51

1.47

g/l

0.28

363

Sulfonylureas

242

1072

1.81

16.14

1.1

1.67

1.55

g/l

4.07

220

949

Enterocolitis due to Clostridium difficile

101

412

2.48

16.03

1.1

1.71

1.53

g/l

3.09

372

Enlarged lymph nodes

148

710

2.11

15.96

1.1

1.53

1.49

g/l

0.50

133

630

Injuries to the head

995

4588

1.34

15.86

1.1

1.52

1.49

g/l

1.02

891

4169

Periodontitis

862

4242

1.36

15.83

1.1

1.53

1.50

g/l

1.15

767

3850

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

245

1389

1.77

15.74

1.1

1.55

1.47

g/l

2.50

218

1267

Diseases of pulp and periapical tissues, including avohilmo

930

3564

1.36

15.72

1.1

1.51

1.50

g/l

0.33

833

3248

Other and unspecified disorders of skin and subcutaneous tissue

267

2.86

15.67

1.0

1.1

1.65

1.52

g/l

1.49

237

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

201

1066

1.88

15.65

1.2

1.1

1.62

1.52

g/l

2.08

184

944

Acute tubulo-interstitial nephritis

498

2894

1.49

15.64

1.1

1.60

1.49

g/l

5.42

454

2596

Other pleural conditions

400

2.48

15.56

1.1

1.72

1.52

g/l

2.81

357

Other symptoms and signs involving the circulatory and respiratory systems

246

2.93

15.55

1.1

1.55

1.47

g/l

0.84

221

Congenital malformations, deformations and chromosomal abnormalities

589

3788

1.44

15.53

1.1

1.49

1.48

g/l

0.24

545

3438

Diseases of the musculoskeletal system and connective tissue

506

1682

1.51

15.52

1.1

1.49

1.48

g/l

0.12

457

1550

Bacterial pneumoniae

333

1814

1.63

15.45

1.1

1.57

1.50

g/l

1.98

315

1629

Vitamin deficiency, wide

175

3.32

15.37

1.1

1.55

1.52

g/l

0.26

159

Vitamin deficiency

175

3.32

15.37

1.1

1.55

1.52

g/l

0.26

159

External causes of morbidity and mortality

599

2064

1.46

15.35

1.1

1.51

1.49

g/l

0.54

538

1880

Intestinal malabsorption

201

3.16

15.31

1.1

1.57

1.48

g/l

1.00

181

Cystitis

714

3038

1.40

15.23

1.1

1.51

1.50

g/l

0.15

653

2740

Other joint disorders

804

3087

1.38

15.13

1.1

1.47

1.49

g/l

0.76

719

2814

Chronic periodontitis, including avohilmo

855

4243

1.36

15.12

1.1

1.53

1.50

g/l

1.09

760

3852

Thiazolidinediones

104

443

2.38

15.05

1.2

1.1

1.58

1.53

g/l

0.60

394

DVT of lower extremities and pulmonary embolism

336

2105

1.60

14.77

1.1

1.52

1.53

g/l

0.18

311

1897

Fissure and fistula of anal and rectal regions

216

1209

1.80

14.77

1.1

1.49

1.50

g/l

0.04

193

1088

Symptoms and signs involving the urinary system

647

3516

1.41

14.71

1.1

1.53

1.52

g/l

0.43

580

3186

Suggestive for eosinophilic asthma

405

2.43

14.71

1.0

1.1

1.42

1.55

g/l

2.29

364

Bacterial pneumonia (organism specified)

355

2047

1.58

14.70

1.1

1.57

1.52

g/l

1.54

333

1834

Psoriasis

270

1612

1.69

14.69

1.1

1.59

1.50

g/l

3.01

250

1461

Ulcerative proctitis

283

2.74

14.62

1.1

1.50

1.48

g/l

0.25

254

Psoriasis vulgaris

186

1001

1.88

14.50

1.1

1.59

1.51

g/l

2.03

175

906

Spondylopathies

689

2955

1.40

14.50

1.1

1.53

1.52

g/l

0.29

616

2685

Gingivitis and periodontal diseases

908

3500

1.34

14.46

1.1

1.50

g/l

0.23

807

3180

Pacemaker

234

1291

1.75

14.42

1.1

1.63

1.55

g/l

2.04

220

1144

Myocarditis

174

3.21

14.12

1.1

1.60

1.41

g/l

2.02

156

L04AC Interleukin inhibitors

300

2.65

14.11

1.1

1.50

1.47

g/l

0.38

275

Diabetic maculopathy, excluding more controls

102

444

2.32

14.07

1.1

1.56

1.50

g/l

0.62

389

Angina pectoris

448

2001

1.50

13.91

1.1

1.55

1.53

g/l

0.67

409

1799

Polycystic ovarian syndrome, consortium definition

560

2313

1.44

13.89

1.1

1.48

g/l

0.11

504

2089

Presence of cardiac and vascular implants and grafts

334

1567

1.59

13.86

1.1

1.61

1.54

g/l

2.48

304

1405

Calcific aortic valvular stenosis, operated

207

1130

1.79

13.82

1.1

1.62

1.56

g/l

1.11

186

1008

Calcific aortic valvular stenosis

207

1130

1.79

13.82

1.1

1.62

1.56

g/l

1.11

186

1008

Papulosquamous disorders

349

2253

1.56

13.80

1.1

1.57

1.50

g/l

2.62

320

2035

Vasomotor and allergic rhinitis

337

2117

1.57

13.78

1.1

1.41

1.50

g/l

4.52

300

1928

Excessive, frequent and irregular menstruation

310

1039

1.64

13.76

1.1

1.47

1.51

g/l

0.84

272

927

Chronic ulcer of skin, not elsewhere classified

275

2.70

13.74

1.0

1.1

1.62

1.55

g/l

0.91

249

Other embolism and thrombosis

116

539

2.18

13.68

1.1

1.57

1.51

g/l

0.63

109

481

Disorders of porphyrin and bilirubin metabolism

6.14

13.67

1.0

1.43

1.38

g/l

0.26

Sicca syndrome [Sjögren]

347

2.49

13.57

1.1

1.48

1.50

g/l

0.27

308

Senile cataract

520

2204

1.45

13.56

1.1

1.57

1.53

g/l

1.45

459

2009

Pruritus

106

477

2.25

13.54

1.1

1.48

1.52

g/l

0.48

432

All influenza

216

1246

1.75

13.36

1.1

1.52

1.49

g/l

0.37

199

1116

Umbilical hernia

245

1464

1.69

13.34

1.1

1.52

g/l

0.03

220

1340

Fracture of rib(s), sternum and thoracic spine

254

1532

1.67

13.34

1.1

1.60

1.52

g/l

1.90

232

1375

Operations 2 for CAVS

205

1129

1.77

13.30

1.1

1.61

1.56

g/l

0.96

184

1007

Calcific aortic valvular stenosis, diagnosis (helper)

205

1129

1.77

13.30

1.1

1.61

1.56

g/l

0.96

184

1007

Elevated blood glucose level

345

2.47

13.25

1.0

1.1

1.47

1.50

g/l

0.33

310

Anaemia in chronic diseases classified elsewhere

3.97

13.18

1.1

1.74

1.48

g/l

1.74

Calcific aortic valvular stenosis, including rheumatic fever

205

1132

1.76

13.14

1.1

1.61

1.56

g/l

0.96

184

1010

Arthropathies

819

3099

1.34

13.09

1.1

1.49

g/l

0.06

742

2826

Coeliac disease

116

549

2.14

13.08

1.1

1.47

1.48

g/l

0.11

103

497

Disorders of the thyroid gland

800

3906

1.34

13.04

1.1

1.49

1.51

g/l

1.15

724

3534

Other arthritis (FG)

275

1703

1.63

13.02

1.1

1.53

1.49

g/l

0.66

255

1537

Other complications of surgical and medical care, not elsewhere classified

100

447

2.27

13.02

1.1

1.54

1.50

g/l

0.55

405

Alcohol-induced chronic pancreatitis

355

2.44

12.99

1.0

1.1

1.58

1.52

g/l

0.75

323

Diseases of spleen

4.60

12.96

1.1

1.51

1.48

g/l

0.23

Other viral diseases

343

2224

1.54

12.86

1.1

1.51

1.48

g/l

0.59

324

2031

Venous thromboembolism

430

2841

1.47

12.83

1.1

1.52

1.53

g/l

0.05

399

2552

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

454

3051

1.45

12.79

1.0

1.1

1.46

1.53

g/l

2.81

400

2784

Psoriatic and enteropathic arthropathies

123

603

2.06

12.67

1.1

1.55

1.48

g/l

1.00

112

541

Benign neoplasm: Sigmoid colon

164

887

1.87

12.65

1.1

1.52

1.54

g/l

0.27

146

792

Special screening examination for infectious and parasitic diseases

213

903

1.75

12.63

1.1

1.42

1.45

g/l

0.44

185

830

Atopic dermatitis, strict definition with reimbursement

275

1656

1.61

12.59

1.1

1.50

1.47

g/l

0.58

258

1514

Bacterial pneumonia, not elsewhere classified

304

1706

1.58

12.52

1.1

1.55

1.50

g/l

1.20

287

1533

Hypothyroidism, other/unspecified

743

3649

1.34

12.51

1.1

1.48

1.51

g/l

1.29

668

3299

Benign neoplasm: Caecum

102

470

2.20

12.36

1.1

1.54

g/l

0.05

418

Other specified/unspecified arthritis

240

1458

1.66

12.31

1.1

1.53

1.50

g/l

0.39

222

1321

Disorders of calcium metabolism

245

2.70

12.27

1.1

1.74

1.49

g/l

3.47

215

Other/unspecified dorsalgia

317

2040

1.55

12.26

1.1

1.48

1.51

g/l

0.91

286

1850

Unspecified acute lower respiratory infection

142

741

1.94

12.25

1.1

1.57

1.52

g/l

1.08

128

670

Pulmonary embolism

229

1378

1.67

12.17

1.1

1.52

1.53

g/l

0.10

213

1233

Menorrhagia

276

941

1.64

12.16

1.1

1.48

1.51

g/l

0.51

242

835

Benign neoplasm: Stomach

422

2.26

12.15

1.1

1.56

1.53

g/l

0.24

378

Care involving dialysis

366

2.36

12.13

1.1

1.67

1.47

g/l

3.63

336

Hyperlipidaemia, other/unspecified

296

1745

1.57

12.04

1.1

1.53

1.54

g/l

0.03

269

1574

Misadventures to patients during surgical and medical care

131

670

1.98

12.00

1.1

1.54

1.51

g/l

0.38

118

608

Benign neoplasm: Ascending colon

124

626

2.00

11.81

1.1

1.51

1.55

g/l

0.62

115

563

Chronic periodontitis, complicated

462

3235

1.42

11.68

1.1

1.58

1.52

g/l

2.63

412

2929

Pulmonary heart disease

229

1394

1.65

11.66

1.1

1.52

1.53

g/l

0.12

213

1246

Other and unspecified rosacea

385

2.29

11.66

1.1

1.53

1.51

g/l

0.13

346

Hypothyreosis and Thyroxine purchase for inclusion criteria

761

3783

1.32

11.62

1.1

1.48

1.51

g/l

1.60

685

3422

Benign neoplasm: Rectum

156

855

1.84

11.59

1.1

1.54

g/l

0.05

138

764

Statin medication

644

2668

1.36

11.57

1.1

1.50

1.49

g/l

0.25

586

2408

Personality disorders, excluding more controls

220

1329

1.67

11.55

1.1

1.52

1.46

g/l

1.31

189

1215

Other CVD

147

791

1.87

11.54

1.1

1.56

g/l

0.00

126

708

Unspecified urinary incontinence

343

2.36

11.52

1.1

1.51

1.53

g/l

0.20

305

Other intervertebral disc disorders

711

3210

1.34

11.52

1.1

1.48

1.51

g/l

1.58

636

2918

Other disorders of veins

320

2100

1.52

11.51

1.1

1.53

1.50

g/l

0.69

281

1891

Benign neoplasm: Rectum, anus and anal canal

169

952

1.79

11.46

1.1

1.55

1.54

g/l

0.10

150

849

Other disorders of white blood cells

243

2.64

11.41

1.1

1.67

1.50

g/l

1.56

218

Conduction disorders

222

1084

1.67

11.41

1.1

1.57

1.50

g/l

1.30

199

962

Other blood glucose lowering drugs, excl. Insulins

124

634

1.97

11.38

1.1

1.58

1.54

g/l

0.58

118

557

Haemorrhoids and perianal venous thrombosis

241

1496

1.62

11.26

1.0

1.1

1.52

g/l

0.01

221

1345

Idiopathic pulmonary fibrosis

280

2.50

11.23

1.1

1.59

1.56

g/l

0.25

252

Spondyloarthritis

153

842

1.83

11.20

1.1

1.52

1.51

g/l

0.22

136

756

Phobic anxiety disorders

129

672

1.93

11.17

1.1

1.52

1.47

g/l

0.60

114

612

Disorders of other endocrine glands

359

2401

1.48

11.16

1.1

1.51

1.50

g/l

0.16

331

2179

Seborrhoeic keratosis

177

1020

1.75

11.11

1.1

1.52

1.53

g/l

0.17

166

910

Diseases of the eye and adnexa

753

2854

1.33

11.09

1.1

1.51

1.48

g/l

1.11

686

2622

Rosacea

108

533

2.05

10.99

1.1

1.51

g/l

0.01

478

Pollen allergy

178

1019

1.74

10.92

1.1

1.41

1.45

g/l

0.77

153

935

Infections with a predominantly sexual mode of transmission

270

1737

1.56

10.90

1.1

1.47

g/l

0.01

238

1588

Persons encountering health services for specific procedures, not carried out

385

2.24

10.80

1.1

1.52

1.46

g/l

0.70

353

Ovarian cyst

277

1015

1.58

10.80

1.1

1.46

1.50

g/l

1.23

256

904

Cutaneous abscess, furuncle and carbuncle

231

1441

1.61

10.73

1.1

1.56

1.49

g/l

1.45

210

1311

Other diseases of urinary system

829

3601

1.30

10.72

1.1

1.52

1.51

g/l

0.24

749

3266

Fentanyl

342

2.30

10.64

1.1

1.72

1.52

g/l

2.64

299

Glomerular diseases

160

908

1.78

10.63

1.1

1.59

1.52

g/l

1.44

144

824

Other and unspecified effects of external causes

247

1570

1.58

10.61

1.1

1.46

1.49

g/l

0.44

233

1431

Ventral hernia

195

1170

1.68

10.58

1.1

1.47

1.53

g/l

1.87

178

1053

119

617

1.95

10.53

1.1

1.57

1.50

g/l

0.98

109

547

Convulsions, not elsewhere classified

191

1126

1.68

10.52

1.1

1.58

1.48

g/l

2.89

171

1016

Other diseases of lip and oral mucosa

338

2305

1.47

10.44

1.1

1.52

1.50

g/l

0.44

310

2086

Generalized anxiety disorder

140

768

1.84

10.41

1.0

1.1

1.43

1.47

g/l

0.61

129

702

Type 1 diabetes

206

1259

1.64

10.34

1.1

1.53

1.47

g/l

1.05

185

1132

Other viral diseases

266

1725

1.55

10.32

1.1

1.50

1.48

g/l

0.28

251

1579

Other diseases of hard tissues of teeth

485

1795

1.40

10.31

1.1

1.51

g/l

0.02

435

1629

Mycoses

721

4828

1.30

10.30

1.1

1.48

1.50

g/l

0.58

641

4385

Open wound of head

448

3107

1.40

10.22

1.1

1.56

1.50

g/l

2.06

399

2822

Diseases of salivary glands

272

1785

1.53

10.15

1.1

1.49

1.51

g/l

0.39

247

1609

Hyperkinetic disorders, excluding more controls

100

472

2.04

10.12

1.1

1.39

1.41

g/l

0.24

434

STROKE

438

2120

1.41

10.10

1.1

1.53

1.49

g/l

0.91

394

1907

Injuries to the ankle and foot

609

4087

1.33

10.08

1.1

1.47

1.49

g/l

0.71

556

3717

Benign neoplasm: Small intestine

172

2.85

10.08

1.1

1.47

1.55

g/l

0.75

155

Major coronary heart disease event excluding revascularizations

454

2167

1.40

10.07

1.1

1.63

1.53

g/l

4.79

407

1941

Glomerular disorders in diseases classified elsewhere

110

565

1.97

10.05

1.1

1.60

1.52

g/l

1.00

101

515

Other abnormal uterine and vaginal bleeding

177

741

1.72

10.02

1.0

1.1

1.45

1.52

g/l

1.72

156

658

Disorders of skin appendages

409

2908

1.41

10.02

1.1

1.48

1.49

g/l

0.18

374

2633

Xerosis cutis

4.51

9.89

1.0

1.2

1.53

1.51

g/l

0.10

Liquid cancers, helper endpoint

277

1595

1.52

9.85

1.1

1.59

1.50

g/l

2.51

251

1428

Injury, poisoning and certain other consequences of external causes

466

1673

1.40

9.81

1.1

1.50

1.48

g/l

0.51

417

1519

Other epidermal thickening

186

2.74

9.78

1.0

1.1

1.56

1.54

g/l

0.09

168

Coxibs

216

694

1.65

9.76

1.1

1.51

1.54

g/l

0.42

191

638

Other arrhythmias

521

2908

1.36

9.69

1.1

1.51

1.49

g/l

0.79

469

2626

Shoulder lesions

630

2890

1.32

9.66

1.1

1.51

1.52

g/l

0.07

568

2624

Symptoms and signs involving cognition, perception, emotional state and behaviour

813

4356

1.28

9.59

1.1

1.50

g/l

0.05

707

3973

Hypothyroidism, strict autoimmune, 3 medication purchases required

675

3498

1.31

9.58

1.1

1.48

1.51

g/l

0.98

603

3161

Ethmoidectomy

122

660

1.87

9.55

1.1

1.45

1.51

g/l

0.98

109

596

Alcohol abuse, main dg, excluding more controls

134

746

1.81

9.55

1.1

1.63

1.50

g/l

2.70

119

680

Cerebral cysts

278

2.37

9.52

1.1

1.58

1.49

g/l

0.89

253

Cardiomyopathy

137

769

1.79

9.49

1.1

1.68

1.50

g/l

5.76

130

689

Peripheral artery disease

303

1631

1.49

9.48

1.1

1.68

1.55

g/l

5.40

268

1459

Unspecific neurodegenerative disorder

1226

0.51

9.47

1.0

1.1

1.60

1.56

g/l

0.36

1078

Other retinal disorders

487

2792

1.36

9.44

1.1

1.53

g/l

0.10

434

2514

Enteropathic arthropathies

104

3.36

9.38

1.1

1.55

1.43

g/l

1.10

Acute alcohol intoxication

210

1325

1.59

9.37

1.1

1.61

1.49

g/l

3.42

185

1205

Alzheimer disease, including avohilmo

1010

0.46

9.37

1.0

1.1

1.60

1.57

g/l

0.28

885

Heartburn

422

2.08

9.33

1.1

1.38

1.49

g/l

2.50

382

Injuries to the knee and lower leg

1004

4487

1.24

9.31

1.1

1.50

g/l

0.15

889

4083

Other female pelvic inflammatory diseases

128

709

1.82

9.29

1.1

1.49

1.50

g/l

0.11

117

640

Other headache syndromes

338

2357

1.44

9.28

1.1

1.44

1.51

g/l

3.20

313

2128

Exposure to other specified factors

642

4540

1.30

9.27

1.1

1.49

1.50

g/l

0.07

577

4130

Intestinal adhesions without obstruction

332

2.22

9.25

1.1

1.59

1.50

g/l

1.04

293

AV-block

122

580

1.85

9.24

1.1

1.62

1.51

g/l

1.60

112

508

Inflammatory diseases of female pelvic organs

454

2436

1.37

9.20

1.1

1.47

1.48

g/l

0.44

413

2193

Injuries to the abdomen, lower back, lumbar spine and pelvis

307

2086

1.46

9.18

1.1

1.53

1.51

g/l

0.47

274

1882

Hypotension

119

647

1.85

9.16

1.1

1.57

1.56

g/l

0.02

102

572

Pain and other conditions associated with female genital organs and menstrual cycle

158

855

1.71

9.14

1.1

1.42

1.50

g/l

1.68

148

764

Sulfasalazine

215

1372

1.58

9.14

1.1

1.50

1.49

g/l

0.12

193

1224

Other diseases of pericardium

187

2.67

9.14

1.1

1.59

1.50

g/l

0.61

169

Hypertensive heart and/or renal disease

188

858

1.64

9.11

1.1

1.63

1.54

g/l

2.09

168

763

Rheumatism, unspecified

117

635

1.86

9.08

1.1

1.44

1.51

g/l

1.30

108

570

Acute alcohol intoxication, ICD10

181

1112

1.64

9.05

1.1

1.63

1.49

g/l

4.00

158

1013

Care involving use of rehabilitation procedures

516

3561

1.34

9.02

1.1

1.51

1.48

g/l

0.75

466

3224

Atopic dermatitis, strict definition

256

1672

1.51

8.90

1.1

1.50

1.47

g/l

0.64

240

1530

Somatoform disorder

142

822

1.74

8.89

1.1

1.45

1.50

g/l

0.92

127

745

Disorders of eyelid, lacrimal system and orbit

687

4065

1.29

8.88

1.1

1.48

1.51

g/l

1.19

613

3686

Hypertensive Heart Disease

169

795

1.67

8.86

1.1

1.63

1.54

g/l

2.27

149

706

Adenocarcinoma and papilloma adenocarcinoma of rectum

351

2.16

8.86

1.1

1.65

1.53

g/l

1.33

305

Colonic or urogenital fistula

228

1487

1.54

8.84

1.1

1.50

1.51

g/l

0.23

202

1355

FESS (DNB20)

116

634

1.85

8.83

1.1

1.44

1.52

g/l

1.17

103

572

Familial hypercholesterolemia

113

612

1.86

8.83

1.1

1.58

1.52

g/l

0.70

103

544

Crohn's disease (strict) with PSC

23.89

8.83

1.2

1.0

1.64

1.15

g/l

—

Presence of other functional implants

423

2129

1.38

8.83

1.1

1.57

1.52

g/l

1.79

378

1904

Adjustment and management of implanted device

123

684

1.81

8.82

1.1

1.65

1.52

g/l

2.41

117

609

Tobacco use

264

2.35

8.74

1.1

1.63

1.49

g/l

1.47

243

Intrahepatic Cholestasis of Pregnancy (ICP)

290

2.27

8.66

1.1

1.41

1.46

g/l

0.33

263

Bipolar affective disorders

164

997

1.66

8.57

1.1

1.47

1.49

g/l

0.16

148

911

Cellulitis

184

1153

1.61

8.51

1.1

1.60

1.50

g/l

2.65

169

1043

Sciatica+with lumbago

421

2847

1.37

8.48

1.1

1.50

1.51

g/l

0.24

384

2590

Myocardial infarction

354

1767

1.41

8.47

1.1

1.68

1.53

g/l

6.89

316

1590

Disorders of choroid and retina

636

3507

1.29

8.45

1.1

1.54

1.52

g/l

0.51

573

3163

Urticaria and erythema

300

2088

1.44

8.43

1.1

1.50

1.49

g/l

0.22

277

1887

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

365

2.10

8.42

1.1

1.65

1.53

g/l

1.27

318

Bronchitis, not specified as acute or chronic

352

2.12

8.41

1.1

1.53

1.52

g/l

0.07

320

Acute gastritis

275

2.28

8.38

1.1

1.61

1.50

g/l

1.15

249

Other and unspecified drugs and medicaments

393

2.06

8.37

1.2

1.1

1.51

g/l

0.00

354

Acetic acid derivatives and related substances

208

680

1.59

8.34

1.1

1.50

1.54

g/l

0.57

185

624

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

295

2.23

8.33

1.1

1.41

1.43

g/l

0.10

268

Exclusions for E4_PCOS_BROAD

150

899

1.68

8.28

1.2

1.1

1.56

1.49

g/l

0.97

140

815

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

415

2.02

8.27

1.2

1.1

1.52

1.50

g/l

0.22

376

Panic disorder

128

737

1.75

8.20

1.1

1.46

1.48

g/l

0.20

111

671

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

245

1650

1.49

8.19

1.1

1.55

1.48

g/l

1.89

218

1505

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

356

2.10

8.19

1.1

1.41

1.48

g/l

0.61

318

Single ventricle heart

18.77

8.16

1.4

1.0

1.59

1.24

g/l

—

Chronic diseases of tonsils and adenoids

667

3300

1.28

8.14

1.1

1.44

1.51

g/l

4.17

607

3012

Poisoning by drugs, medicaments and biological substances

206

1341

1.55

8.10

1.1

1.55

1.48

g/l

1.82

177

1220

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

230

1514

1.51

8.10

1.1

1.47

1.48

g/l

0.21

206

1390

Other malignant neoplasms of skin (=non-melanoma skin cancer)

317

1528

1.43

8.00

1.1

1.50

1.51

g/l

0.09

287

1361

Symptoms and signs involving speech and voice

256

1749

1.47

7.98

1.1

1.50

1.51

g/l

0.16

231

1581

Transport accidents

371

2320

1.38

7.97

1.1

1.48

1.49

g/l

0.27

333

2129

Extracorporeal dialysis

301

2.19

7.97

1.1

1.67

1.52

g/l

1.65

279

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

342

1655

1.41

7.93

1.1

1.51

g/l

0.01

309

1475

Lung cancer and mesothelioma

115

551

1.80

7.92

1.1

1.62

1.54

g/l

1.15

102

484

Paracetamol or NSAID medication

139

401

1.75

7.91

1.1

1.49

1.48

g/l

0.11

127

375

Fenamates

115

431

1.82

7.91

1.1

1.45

1.57

g/l

2.73

107

395

In situ neoplasms

271

1877

1.45

7.86

1.1

1.53

1.52

g/l

0.13

254

1688

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

362

2.07

7.85

1.1

1.41

1.45

g/l

0.36

325

Allergic rhinitis

265

1812

1.45

7.75

1.1

1.41

1.47

g/l

2.23

234

1657

Anti-inflammatory and antirheumatic products, non-steroids

225

738

1.54

7.74

1.1

1.51

1.53

g/l

0.23

201

678

Other cataract

330

1785

1.40

7.73

1.1

1.55

1.52

g/l

0.65

295

1624

Disorders of lacrimal system

328

2352

1.40

7.72

1.0

1.1

1.47

1.51

g/l

0.83

292

2121

Adverse effects, not elsewhere classified

163

1018

1.61

7.70

1.1

1.46

1.49

g/l

0.47

156

915

Disorder of lipoprotein metabolism, unspecified

539

1.85

7.68

1.1

1.58

1.52

g/l

0.67

482

Alcohol withdrawal state with delirium

373

2.04

7.65

1.1

1.74

1.53

g/l

3.83

337

Other problems related to primary support group, including family circumstances

104

560

1.82

7.63

1.1

1.48

1.45

g/l

0.38

512

Voice disturbances

211

1400

1.52

7.63

1.1

1.48

1.52

g/l

0.74

193

1265

Lung diseases due to external agents

105

584

1.81

7.60

1.1

1.59

1.54

g/l

0.57

519

Poisoning by medicine

188

1218

1.55

7.59

1.1

1.55

1.48

g/l

1.57

162

1111

Type 1 diabetes, wide definition, subgroup 1

163

1022

1.60

7.54

1.1

1.54

1.46

g/l

1.74

148

916

Degeneration of nervous system due to alcohol

103

3.09

7.54

1.1

1.62

1.56

g/l

0.37

Infection due to other mycobacteria

4.33

7.52

1.1

1.0

1.48

1.52

g/l

0.17

Disorders of muscles

458

1.92

7.51

1.1

1.50

1.48

g/l

0.30

415

Use of anticholinesterases

1050

0.50

7.51

1.0

1.1

1.59

1.57

g/l

0.15

923

N06DA Anticholinesterases

1050

0.50

7.51

1.0

1.1

1.59

1.57

g/l

0.15

923

DVT of lower extremities

133

795

1.68

7.48

1.1

1.52

g/l

0.06

123

709

Superficial injury of thorax

124

728

1.72

7.47

1.1

1.54

1.50

g/l

0.50

109

654

L01XE Protein kinase inhibitors

245

2.28

7.43

1.1

1.60

1.53

g/l

0.73

222

Fracture of lumbar spine and pelvis

152

941

1.62

7.40

1.1

1.63

1.53

g/l

1.66

136

837

Atopic dermatitis

478

2991

1.31

7.39

1.1

1.50

1.47

g/l

0.97

438

2723

Propionic acid derivatives

223

738

1.52

7.39

1.1

1.51

1.53

g/l

0.35

198

678

Intracranial injury

453

3260

1.32

7.33

1.1

1.49

1.50

g/l

0.14

398

2964

Malignant neoplasm of rectum

358

2.03

7.32

1.1

1.65

1.53

g/l

1.65

312

Atherosclerosis, excluding cerebral and coronary sclerosis

267

1472

1.44

7.31

1.1

1.70

1.56

g/l

5.95

236

1313

Disorders of synovium and tendon

421

2775

1.33

7.29

1.1

1.45

1.50

g/l

2.23

373

2519

Fracture of shoulder and upper arm

277

1953

1.42

7.28

1.1

1.61

1.50

g/l

4.09

244

1770

Infections with a predominantly sexual mode of transmission

323

2180

1.39

7.22

1.1

1.46

g/l

0.17

283

1997

Other diseases of blood and blood-forming organs

327

2.07

7.21

1.1

1.52

1.51

g/l

0.01

290

Emotional disorders starting during childhood or adolecense, excluding more controls

146

2.63

7.20

1.2

1.1

1.45

1.40

g/l

0.42

129

Urticaria

244

1688

1.45

7.18

1.1

1.51

1.49

g/l

0.25

223

1528

Alcohol-induced acute pancreatitis

199

2.41

7.17

1.1

1.72

1.49

g/l

2.04

180

Disorders of oesophagus in diseases classified elsewhere

3.51

7.16

1.1

1.63

1.51

g/l

0.58

Disorders of adult personality and behaviour

240

1656

1.46

7.16

1.1

1.51

1.48

g/l

0.57

206

1519

Dental operations

491

1922

1.32

7.14

1.1

1.52

1.51

g/l

0.13

439

1731

Malignant neoplasm of rectum, including Hilmo

473

1.87

7.14

1.1

1.62

1.53

g/l

1.19

420

Amputation

410

1.94

7.13

1.1

1.65

1.54

g/l

1.56

366

KRA_PSY_EATING, excluding more controls

280

2.15

7.12

1.1

1.50

1.45

g/l

0.44

260

Degeneration of the brain due to alcohol

107

2.97

7.08

1.1

1.62

1.55

g/l

0.50

Enthesopathies of lower limb, excluding foot

188

1240

1.52

7.03

1.1

1.49

1.51

g/l

0.15

172

1122

Irregular menses

350

2031

1.37

7.02

1.1

1.47

g/l

0.13

321

1840

Basal cell carcinoma

296

1460

1.41

6.99

1.1

1.51

g/l

0.03

264

1299

Diseases of oral cavity, salivary glands and jaws

462

1802

1.32

6.97

1.1

1.52

1.51

g/l

0.28

414

1635

Lumbar disc prolapse

519

3096

1.29

6.96

1.1

1.46

1.51

g/l

2.52

466

2818

Diseases of the ear and mastoid process

993

4134

1.21

6.96

1.1

1.49

1.50

g/l

0.20

897

3757

Acute suppurative otitis media

219

1391

1.48

6.95

1.1

1.44

1.45

g/l

0.16

208

1263

Non-selective monoamine reuptake inhibitors

279

1917

1.41

6.92

1.1

1.51

1.52

g/l

0.03

253

1739

Supplementary factors related to causes of morbidity and mortality classified elsewhere

252

1767

1.43

6.92

1.1

1.54

1.50

g/l

1.01

226

1604

Spondylopathies (FG)

121

722

1.69

6.90

1.1

1.50

1.47

g/l

0.36

109

655

Other enthesopathies

240

1670

1.44

6.87

1.1

1.44

1.51

g/l

1.89

217

1518

Dental caries, including avohilmo

594

2389

1.27

6.83

1.1

1.52

1.51

g/l

0.28

531

2168

Malignant neoplasm of skin

347

1748

1.36

6.82

1.1

1.49

1.51

g/l

0.46

315

1558

Idiopathic gout

403

1.93

6.81

1.1

1.64

1.57

g/l

0.61

357

Viral infections characterized by skin and mucous membrane lesions

695

4803

1.24

6.81

1.1

1.49

1.50

g/l

0.17

643

4341

Thyroiditis, ILD-related definition

496

1.83

6.78

1.1

1.49

g/l

0.06

450

Dementia

118

1335

0.61

6.74

1.0

1.1

1.61

1.56

g/l

0.58

102

1182

Localized swelling, mass and lump of skin and subcutaneous tissue

247

1735

1.43

6.73

1.1

1.53

1.51

g/l

0.44

236

1559

Special screening examination for other diseases and disorders

440

1.88

6.70

1.1

1.50

1.51

g/l

0.17

396

Peripheral arterial reconstruction

112

660

1.71

6.69

1.1

1.74

1.56

g/l

4.41

100

595

Osteomyelitis

303

2.07

6.67

1.1

1.59

1.52

g/l

0.63

272

Unspecified fall

382

2839

1.33

6.67

1.1

1.52

1.50

g/l

0.44

335

2583

Maternal care for other conditions predominantly related to pregnancy

159

1004

1.56

6.64

1.1

1.41

1.48

g/l

1.21

146

919

Injuries to the shoulder and upper arm

679

4425

1.24

6.59

1.1

1.55

1.50

g/l

2.11

603

4019

Disorders of sclera, cornea, iris and ciliary body

433

3332

1.30

6.57

1.1

1.53

1.50

g/l

0.76

395

3019

Occupational exposure to risk-factors

164

2.49

6.56

1.0

1.1

1.42

1.54

g/l

1.11

150

Diseases of the myoneural junction and muscle

569

1.75

6.50

1.1

1.56

1.52

g/l

0.46

505

Morphin

3.57

6.47

1.3

1.1

1.54

1.50

g/l

0.32

Nonorganic sleeping disorders, excluding more controls

149

952

1.57

6.47

1.1

1.55

1.47

g/l

1.65

133

875

Dementia, including avohilmo

134

1455

0.63

6.46

1.0

1.1

1.60

1.56

g/l

0.48

117

1289

Basal cell carcinoma, including avohilmo

308

1545

1.38

6.45

1.1

1.51

g/l

0.01

275

1375

Other disorders of lacrimal gland

265

1901

1.40

6.43

1.0

1.1

1.47

1.51

g/l

0.90

231

1710

Internal derangement of knee

299

2177

1.37

6.42

1.1

1.50

1.51

g/l

0.15

258

1972

Metatarsalgia

412

1.88

6.39

1.0

1.1

1.43

1.49

g/l

0.83

370

Barrett oesophagus

197

2.32

6.38

1.1

1.53

g/l

0.02

180

Endometriosis

242

988

1.44

6.37

1.1

1.45

1.50

g/l

1.22

225

877

Extreme obesity with alveolar hypoventilation

179

2.38

6.34

1.0

1.1

1.58

1.52

g/l

0.52

163

Cardiodefibrillation

246

1743

1.41

6.32

1.1

1.60

1.55

g/l

1.30

237

1550

Other specified/unspecified bacterial intestinal infections

296

2.05

6.32

1.2

1.1

1.57

1.51

g/l

0.42

270

Seborrhoeic dermatitis

457

1.83

6.31

1.1

1.51

1.53

g/l

0.22

416

Faecal incontinence

297

2.04

6.24

1.1

1.53

1.52

g/l

0.03

261

Unspecified haematuria

302

1837

1.37

6.23

1.1

1.54

g/l

0.01

270

1649

Rotator cuff syndrome

476

2665

1.28

6.22

1.1

1.53

1.52

g/l

0.14

438

2419

Any dementia

1129

0.59

6.22

1.0

1.1

1.61

1.57

g/l

0.53

996

Injuries to the wrist and hand

819

4699

1.21

6.20

1.1

1.49

1.50

g/l

0.36

733

4274

Carpal tunnel syndrome

474

3272

1.28

6.20

1.1

1.48

1.51

g/l

1.16

419

2956

Varicose veins of other sites

326

1.99

6.18

1.1

1.61

1.48

g/l

0.98

292

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

139

856

1.58

6.18

1.1

1.52

1.48

g/l

0.52

134

771

Caries of dentine, including avohilmo

631

2587

1.25

6.16

1.1

1.53

1.50

g/l

1.06

563

2354

Fracture of foot, except ankle

198

1360

1.46

6.13

1.1

1.47

1.50

g/l

0.42

180

1238

Fall on same level involving ice and snow

443

3453

1.29

6.13

1.1

1.50

g/l

0.06

393

3123

Vitamin B12 deficiency anaemia

383

1.89

6.10

1.1

1.52

1.53

g/l

0.07

338

Migraine

379

2341

1.32

6.06

1.1

1.41

1.49

g/l

3.95

355

2119

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

164

964

1.52

6.06

1.1

1.41

1.43

g/l

0.28

149

884

Malignant neoplasm of pancreas, including Hilmo

287

2.04

6.05

1.1

1.80

1.53

g/l

2.46

244

Other and unspecified nerve root and plexus disorders, also in other diseases

163

1081

1.52

6.02

1.1

1.48

1.51

g/l

0.49

143

986

Superficial injury of head

176

1186

1.49

6.00

1.1

1.54

1.50

g/l

0.46

160

1066

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

141

909

1.56

5.94

1.1

1.58

1.47

g/l

2.33

120

826

Periapical abscess

369

2821

1.31

5.94

1.1

1.51

g/l

0.00

325

2556

Other predominantly sexually transmitted diseases, not elsewhere classified

139

894

1.56

5.92

1.1

1.41

1.47

g/l

1.16

125

812

Secondary uncertain malignant neoplasm

518

1.75

5.91

1.1

1.69

1.51

g/l

2.61

455

Suicide or other Intentional self-harm

203

1412

1.45

5.91

1.1

1.59

1.49

g/l

3.06

177

1286

Other predominantly sexually transmitted diseases, not elsewhere classified

164

1094

1.51

5.90

1.1

1.41

1.47

g/l

1.23

150

997

Caries of enamel

740

4413

1.21

5.79

1.1

1.44

1.50

g/l

3.89

661

4017

Laparoscopic right hemicolectomy

232

2.14

5.78

1.1

1.54

1.56

g/l

0.15

207

All influenza (not pneumonia)

117

727

1.62

5.77

1.1

1.52

1.49

g/l

0.27

107

657

Diseases of pulp and periapical tissues and dental caries

523

2122

1.27

5.76

1.1

1.52

1.51

g/l

0.44

469

1927

Necrosis of pulp, including avohilmo

474

3749

1.26

5.72

1.1

1.50

1.49

g/l

0.16

427

3414

Social phobias

406

1.84

5.72

1.0

1.1

1.51

1.44

g/l

0.85

372

Right bundle-branch block

144

2.46

5.72

1.1

1.64

1.53

g/l

0.93

125

Myocardial infarction, strict

310

1644

1.35

5.71

1.1

1.66

1.53

g/l

4.91

275

1476

Disturbances of skin sensation

217

1538

1.42

5.71

1.1

1.44

1.50

g/l

1.97

198

1392

Aortic aneurysm

154

1002

1.51

5.68

1.1

1.57

1.55

g/l

0.21

139

906

Alcohol abuse, main dg

134

864

1.56

5.67

1.1

1.63

1.50

g/l

2.56

119

785

Other and unspecified epidermal thickening

2.80

5.66

1.0

1.1

1.57

1.51

g/l

0.24

Viral infections characterized by skin and mucous membrane lesions

327

2476

1.32

5.63

1.1

1.51

1.50

g/l

0.09

305

2246

Type 1 diabetes, wide definition

165

1114

1.49

5.59

1.1

1.54

1.47

g/l

1.37

150

1002

Other and unspecified myopathies

381

1.85

5.57

1.1

1.59

1.53

g/l

0.54

339

Disturbance of activity and attention

576

1.68

5.56

1.1

1.38

1.42

g/l

0.75

528

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

380

1.85

5.55

1.1

1.47

1.56

g/l

1.18

326

Congenital malformations of the circulatory system

122

750

1.59

5.55

1.1

1.48

g/l

0.06

113

679

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

165

2.33

5.53

1.1

1.0

1.53

1.56

g/l

0.11

141

Persistent mood disorders

146

965

1.52

5.52

1.1

1.49

1.51

g/l

0.30

129

869

Magnesium deficiency

17.08

5.49

1.0

1.78

1.46

g/l

—

Other follicular disorders

348

1.89

5.46

1.0

1.1

1.55

1.47

g/l

0.84

317

Other arthrosis

416

2250

1.28

5.45

1.1

1.50

1.52

g/l

0.43

365

2043

Open wound of lower leg

116

731

1.60

5.43

1.1

1.53

1.52

g/l

0.11

662

Fall on and from stairs and steps

193

1354

1.43

5.40

1.1

1.54

1.52

g/l

0.30

175

1217

Sequelae of external causes of morbidity and mortality

185

1288

1.44

5.40

1.1

1.54

1.52

g/l

0.29

177

1148

Post-traumatic stress disorder

378

1.84

5.39

1.1

1.54

1.46

g/l

1.07

342

Spondylosis

408

2603

1.28

5.38

1.1

1.53

g/l

0.03

367

2370

Personality disorders

220

1582

1.40

5.35

1.1

1.52

1.48

g/l

0.78

189

1450

Personal history of other diseases and conditions

510

1.71

5.31

1.1

1.54

1.46

g/l

0.92

461

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

142

914

1.52

5.28

1.1

1.51

1.48

g/l

0.28

137

825

Abscess of anal and rectal regions

410

1.80

5.27

1.1

1.44

1.48

g/l

0.46

368

Soft tissue disorders related to use, overuse and pressure

201

1427

1.41

5.27

1.1

1.48

1.52

g/l

0.77

182

1293

Other shoulder lesions

425

1.78

5.25

1.0

1.1

1.53

1.47

g/l

0.64

382

Polyarthrosis

142

875

1.51

5.23

1.0

1.1

1.59

1.52

g/l

1.01

124

784

Chronic tubulo-interstitial nephritis

132

2.45

5.22

1.0

1.1

1.66

1.48

g/l

1.37

118

Arthropathy in ulcerative colitis

3.31

5.22

1.2

1.0

1.56

1.44

g/l

0.69

Other enthesopathy of foot (+metatarsalgia)

463

1.74

5.21

1.1

1.43

1.49

g/l

0.86

417

Melanocytic naevi

227

1650

1.38

5.19

1.1

1.43

1.50

g/l

2.56

213

1497

Other viral diseases, not elsewhere classified

213

1524

1.40

5.18

1.1

1.51

1.48

g/l

0.60

206

1395

Dental pulpitis, including avohilmo

766

4167

1.20

5.16

1.1

1.48

1.49

g/l

0.41

695

3784

Type of accident

221

1602

1.39

5.14

1.1

1.53

1.50

g/l

0.56

199

1452

Viral pneumonia (unknown virus, not influenza)

327

1.88

5.13

1.1

1.55

1.50

g/l

0.30

300

Hyperkinetic disorders

102

619

1.62

5.12

1.1

1.39

1.43

g/l

0.80

570

Suppurative and unspecified otitis media

279

1855

1.34

5.11

1.1

1.46

1.47

g/l

0.14

265

1683

Tubulo-interstitial nephritis, not specified as acute or chronic

251

2.01

5.08

1.1

1.63

1.51

g/l

0.86

227

Diabetic retinopathy, excluding more controls

239

972

1.39

5.07

1.1

1.56

1.52

g/l

0.86

217

872

Acquired haemolytic anaemia

2.81

5.07

1.2

1.1

1.66

1.55

g/l

0.77

Drug-induced osteoporosis with pathological fracture

3.35

5.06

1.1

1.71

1.50

g/l

1.40

Persons with potential health hazards related to communicable diseases

301

2273

1.32

5.04

1.1

1.46

1.47

g/l

0.23

283

2076

Mixed and other personality disorders

409

1.78

5.03

1.1

1.50

1.46

g/l

0.42

375

Congenital malformation of biliary tract

8.43

4.99

1.0

1.51

1.31

g/l

—

Viral and other specified intestinal infections

159

1068

1.46

4.95

1.1

1.52

1.44

g/l

1.91

150

965

Sequelae with surgical and medical care as external cause

146

989

1.48

4.95

1.1

1.59

1.53

g/l

0.96

141

884

Other peripheral vascular diseases

346

1.84

4.92

1.1

1.49

1.51

g/l

0.12

315

Emotional disorders starting during childhood or adolescence

179

2.18

4.90

1.2

1.1

1.45

1.44

g/l

0.07

160

Olecranon bursitis

297

1.91

4.89

1.1

1.58

1.48

g/l

0.98

264

Other diseases of oesophagus

347

1.83

4.87

1.1

1.57

1.51

g/l

0.48

308

Disorders of parathyroid gland

134

884

1.50

4.87

1.0

1.1

1.51

1.54

g/l

0.30

117

779

Viral and other specified intestinal infections

211

1479

1.38

4.84

1.1

1.51

1.45

g/l

1.30

195

1340

Dizziness and giddiness

567

3697

1.22

4.82

1.1

1.49

1.51

g/l

0.96

500

3356

Retention of urine

226

1360

1.37

4.80

1.1

1.57

1.55

g/l

0.39

204

1222

Other extrapyramidal and movement disorders in other diseases

167

1172

1.43

4.73

1.1

1.47

1.53

g/l

1.53

150

1053

Speech therapy

189

1356

1.40

4.72

1.1

1.47

1.53

g/l

1.16

169

1225

Superficial injury of abdomen, lower back and pelvis

111

718

1.55

4.70

1.1

1.42

1.49

g/l

1.45

100

643

Disease of hard tissues of teeth, NOS

423

1757

1.26

4.69

1.1

1.49

1.51

g/l

0.36

379

1592

Symptoms and signs involving the nervous and musculoskeletal systems

421

3378

1.25

4.67

1.1

1.51

g/l

0.08

395

3046

Ankylosing spondylitis

449

1.71

4.65

1.1

1.52

1.48

g/l

0.38

404

Left ventricular outflow tract obstruction (LVOTO), broad definition

564

1.63

4.64

1.1

1.57

1.50

g/l

0.89

515

Use of memantine

765

0.54

4.63

1.0

1.1

1.65

1.59

g/l

0.70

671

Use of other anti-dementia drugs

765

0.54

4.63

1.0

1.1

1.65

1.59

g/l

0.70

671

Rheumatoid arthritis

231

1540

1.35

4.57

1.1

1.53

1.51

g/l

0.43

207

1393

Phlebitis and thrombophlebitis (not including DVT)

152

1057

1.44

4.54

1.1

1.53

1.51

g/l

0.33

142

949

Diseases of middle ear and mastoid

438

2892

1.24

4.52

1.1

1.47

1.48

g/l

0.21

404

2620

Visual disturbances and blindness

375

2983

1.26

4.52

1.1

1.48

1.51

g/l

0.67

339

2701

Lichen simplex chronicus and prurigo

284

1.88

4.51

1.1

1.50

1.51

g/l

0.06

256

Vitreous haemorrhage

476

1.67

4.51

1.1

1.59

1.52

g/l

0.79

427

Infectious mononucleosis

409

1.72

4.47

1.0

1.1

1.48

1.45

g/l

0.25

371

Burns and corrosions

113

744

1.53

4.45

1.1

1.56

1.49

g/l

0.85

100

672

Fracture of lower leg, including ankle

421

3365

1.24

4.45

1.1

1.52

1.50

g/l

0.42

386

3060

Thyrotoxicosis, other and/or unspecified

146

1012

1.45

4.45

1.0

1.1

1.49

1.50

g/l

0.12

134

913

Raynaud syndrome

410

1.72

4.44

1.1

1.45

1.49

g/l

0.42

370

Unstable angina pectoris

229

1344

1.35

4.43

1.1

1.55

1.54

g/l

0.09

210

1189

Burns and corrosions of external body surface, specified by site

564

1.61

4.41

1.1

1.58

1.49

g/l

1.03

510

Presence of other devices

136

929

1.46

4.37

1.1

1.50

1.53

g/l

0.55

128

828

Corns and callosities

280

1.87

4.37

1.0

1.1

1.57

1.49

g/l

0.54

247

Excessive attrition of teeth

438

3561

1.23

4.37

1.1

1.48

1.49

g/l

0.26

395

3234

Peripheral artery operations in Hilmo

495

1.64

4.37

1.1

1.61

1.55

g/l

0.75

446

Calculus of kidney and ureter

212

1572

1.35

4.36

1.1

1.46

1.53

g/l

1.64

193

1417

Hypertrophic disorders of skin

238

1.95

4.35

1.2

1.1

1.65

1.47

g/l

1.55

215

Status post-ami

160

858

1.43

4.33

1.1

1.64

1.55

g/l

1.87

143

753

Behavioural syndromes associated with physiological disturbances and physical factors

732

4412

1.18

4.33

1.1

1.48

1.49

g/l

0.30

666

3996

Epilepsy

220

1637

1.34

4.32

1.1

1.53

1.51

g/l

0.23

201

1483

Abnormalities of gait and mobility

552

1.60

4.30

1.1

1.52

1.54

g/l

0.08

490

Migraine with aura

173

1244

1.40

4.30

1.1

1.37

1.49

g/l

4.74

165

1127

Injuries to the elbow and forearm

540

3941

1.21

4.29

1.1

1.51

1.49

g/l

0.54

480

3569

Degeneration of macula and posterior pole

290

1787

1.29

4.25

1.1

1.52

1.55

g/l

0.66

255

1591

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

7.36

4.24

1.4

1.1

1.80

1.34

g/l

—

Medical abortion

431

1886

1.24

4.23

1.1

1.53

1.48

g/l

2.05

385

1692

Abnormality of white blood cells, not elsewhere classified

4.95

4.23

1.1

1.0

1.68

1.43

g/l

1.07

Other coagulation defects

320

1.80

4.21

1.2

1.1

1.49

1.50

g/l

0.04

291

Thyrotoxicosis

180

1309

1.38

4.20

1.1

1.49

1.51

g/l

0.33

166

1176

Hyperparathyroidism

114

753

1.50

4.20

1.0

1.1

1.50

1.54

g/l

0.50

659

Haemangioma and lymphangioma, any site

441

1.67

4.16

1.2

1.1

1.38

1.50

g/l

1.88

397

Other symptoms and signs involving cognitive functions and awareness

313

2241

1.27

4.15

1.1

1.55

1.53

g/l

0.46

269

2030

Trigger finger

107

708

1.52

4.14

1.1

1.46

1.50

g/l

0.51

638

Other infectious diseases

396

1.70

4.14

1.1

1.63

1.52

g/l

1.24

360

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

352

1.75

4.11

1.1

1.55

1.52

g/l

0.23

319

Any dementia, excluding more controls

982

0.65

4.10

1.0

1.1

1.61

1.56

g/l

0.66

867

Use of pramipexole

148

1049

1.42

4.04

1.1

1.53

g/l

0.05

128

933

Other/unspecified enthesopathies of lower limb, excluding foot

340

1.75

4.00

1.1

1.44

1.48

g/l

0.43

307

Polyuria

148

1051

1.41

4.00

1.1

1.52

1.53

g/l

0.11

135

944

Arthrosis

554

2534

1.20

3.98

1.1

1.52

1.51

g/l

0.21

491

2302

Emotional disorders and disorders of social functioning with onset specific to childhood

201

1.97

3.94

1.2

1.1

1.44

1.43

g/l

0.08

181

Other disorders of glucose regulation and pancreatic internal secretion

402

1.68

3.94

1.1

1.57

1.50

g/l

0.60

368

Herpesviral [herpes simplex] infections

565

1.57

3.93

1.0

1.1

1.52

1.49

g/l

0.19

509

Sleep disorders

699

4317

1.17

3.92

1.1

1.48

1.49

g/l

0.31

633

3908

Mental and behavioural disorders due to sedatives or hypnotics

350

1.73

3.92

1.1

1.61

1.45

g/l

2.04

314

Degenerative diseases of the nervous system

1026

0.66

3.90

1.1

1.58

1.57

g/l

0.08

908

Other inflammation of eyelid

646

1.53

3.89

1.1

1.55

1.52

g/l

0.30

581

Disorders of tooth development and eruption

124

690

1.46

3.88

1.1

1.46

1.48

g/l

0.28

113

626

Fibroblastic disorders

154

1111

1.39

3.81

1.1

1.54

1.52

g/l

0.29

141

1000

Nasal polyp

142

1011

1.41

3.80

1.1

1.48

1.53

g/l

0.67

125

920

Valvular operations

603

1.53

3.76

1.1

1.61

1.50

g/l

1.30

539

Superficial injury of hip and thigh

627

1.52

3.75

1.1

1.50

1.51

g/l

0.16

563

Polymyalgia rheumatica

493

1.59

3.74

1.0

1.1

1.64

1.56

g/l

0.74

435

Eating disorder

354

1.70

3.74

1.1

1.50

1.44

g/l

0.49

326

Infective dermatitis

550

1.55

3.70

1.1

1.56

1.53

g/l

0.33

496

Other necrotizing vasculopathies

282

1.79

3.68

1.1

1.57

1.52

g/l

0.26

254

Spontaneous rupture of synovium and tendon

349

1.70

3.68

1.1

1.54

1.49

g/l

0.46

311

Urolithiasis

221

1695

1.31

3.67

1.1

1.46

1.53

g/l

1.88

200

1531

Specific personality disorders

179

1333

1.35

3.65

1.1

1.52

1.48

g/l

0.72

152

1221

Other melanin hyperpigmentation

2.57

3.65

1.1

1.51

1.54

g/l

0.15

Other and unspecified haemorrhagic conditions

2.91

3.65

1.3

1.1

1.42

1.45

g/l

0.13

Keratitis

263

2067

1.28

3.62

1.1

1.52

1.49

g/l

0.34

237

1870

Emotionally unstable personality disorder

609

1.52

3.61

1.1

1.50

1.46

g/l

0.39

556

Dermatophytosis

626

1.51

3.59

1.1

1.58

1.52

g/l

0.62

560

Palmar fascial fibromatosis [Dupuytren]

650

1.50

3.59

1.0

1.1

1.57

1.52

g/l

0.68

577

Zoster [herpes zoster]

336

2677

1.24

3.57

1.1

1.53

1.51

g/l

0.20

314

2394

Restless leg syndrome

619

1.51

3.57

1.1

1.48

1.50

g/l

0.25

559

Adhesive capsulitis of shoulder

117

815

1.44

3.56

1.1

1.48

1.51

g/l

0.66

111

733

Thoracic aortic aneurysm

100

676

1.49

3.56

1.0

1.1

1.51

1.53

g/l

0.20

612

Personal history of allergy to drugs, medicaments and biological substances

3.11

3.56

1.0

1.30

1.42

g/l

0.55

Erosion of teeth , including avohilmo

189

1426

1.33

3.55

1.1

1.48

1.49

g/l

0.11

168

1299

Inflammatory diseases of prostate (prostatitis)

101

685

1.48

3.54

1.1

1.47

1.53

g/l

0.94

627

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

108

742

1.46

3.54

1.1

1.47

1.48

g/l

0.25

100

670

Diabetic neuropathy

102

691

1.48

3.52

1.1

1.59

1.53

g/l

1.04

635

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

285

2260

1.26

3.51

1.0

1.1

1.47

1.48

g/l

0.16

261

2059

Degenerative macular diseases

470

1.58

3.50

1.1

1.50

1.55

g/l

0.50

416

Oter anti-inflammatory and antirheumatic agents, non-steroids

134

521

1.42

3.49

1.1

1.53

1.58

g/l

0.66

117

480

Other and unspecified local infections of skin and subcutaneous tissue

448

1.59

3.47

1.1

1.53

1.50

g/l

0.34

407

Childhood allergy (age < 16)

102

571

1.48

3.45

1.1

1.42

1.41

g/l

0.09

522

Hydronephrosis

480

1.57

3.44

1.1

1.60

1.50

g/l

1.30

428

Anogenital herpesviral [herpes simplex] infection

266

1.78

3.44

1.1

1.55

1.46

g/l

0.66

245

Sub-endpoint used in defining T1D endpoints

205

1546

1.31

3.43

1.1

1.53

1.49

g/l

0.75

184

1402

Ankylosing spondylitis, ICD10

473

1.58

3.43

1.1

1.52

1.48

g/l

0.43

430

Insomnia

677

4258

1.16

3.41

1.1

1.48

1.49

g/l

0.41

617

3856

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

242

1902

1.28

3.37

1.1

1.49

1.50

g/l

0.18

228

1713

Other obstetric conditions, not elsewhere classified

208

1011

1.31

3.36

1.1

1.43

1.46

g/l

0.47

201

923

Congenital absence, atresia and stenosis of large intestine

9.44

3.35

1.0

1.66

1.31

g/l

—

Superficial injury of wrist and hand

150

1104

1.36

3.34

1.1

1.52

1.49

g/l

0.49

135

1010

Acute pharyngitis

114

794

1.43

3.34

1.1

1.41

1.49

g/l

1.53

109

726

Other local infections of skin and subcutaneous tissue

476

1.56

3.34

1.1

1.53

1.50

g/l

0.23

432

Deviated nasal septum

246

1938

1.27

3.33

1.1

1.46

1.54

g/l

3.25

219

1771

Etanercept

315

1.70

3.29

1.1

1.42

1.49

g/l

0.82

285

Demyelinating diseases of the central nervous system

415

1.60

3.29

1.1

1.48

1.49

g/l

0.05

378

Other disorders of patella

134

972

1.38

3.28

1.0

1.1

1.45

1.48

g/l

0.55

116

890

Open wound of forearm

455

1.57

3.27

1.1

1.59

1.51

g/l

0.86

407

Malignant melanoma

599

1.49

3.27

1.1

1.44

1.52

g/l

1.79

527

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

463

1.56

3.27

1.1

1.53

1.52

g/l

0.08

413

Visual impairment including blindness (binocular or monocular)

286

1.73

3.25

1.0

1.1

1.56

g/l

0.02

260

Other and unspecified coagulation defects

220

1.83

3.24

1.2

1.1

1.49

g/l

0.01

202

Myocardial infarction, without ST-elevation

239

1716

1.27

3.23

1.1

1.67

1.55

g/l

3.20

211

1532

Primary_lymphoid and hematopoietic malignant neoplasms

155

1154

1.35

3.22

1.1

1.61

1.53

g/l

1.15

146

1026

Nonorganic sleeping disorders

149

1103

1.36

3.22

1.1

1.55

1.49

g/l

1.03

133

1005

Golimumab

164

1.97

3.21

1.0

1.1

1.48

1.44

g/l

0.24

149

Exclusions for E4_PCOS_CONSORTIUM

521

2774

1.18

3.16

1.1

1.49

1.48

g/l

0.37

472

2512

Seropositive rheumatoid arthritis

164

1232

1.33

3.13

1.1

1.55

1.51

g/l

0.74

143

1113

Procreative management

269

1799

1.25

3.11

1.1

1.46

1.48

g/l

0.34

245

1642

Spinal stenosis

338

2108

1.22

3.08

1.1

1.56

1.54

g/l

0.48

297

1911

Other maternal disorders predominantly related to pregnancy

395

2060

1.20

3.08

1.1

1.44

1.48

g/l

1.06

362

1859

Striking against or struck by other objects

254

2032

1.25

3.06

1.1

1.47

1.48

g/l

0.10

230

1853

Nummular dermatitis

384

1.60

3.05

1.0

1.1

1.59

1.54

g/l

0.26

344

Need for other prophylactic measures

292

1.69

3.04

1.1

1.49

g/l

0.01

261

Contact with heat and hot substances

277

1.71

3.04

1.1

1.56

1.48

g/l

0.65

253

Migraine without aura

139

1029

1.36

3.02

1.1

1.36

1.48

g/l

3.72

129

939

Other disorders of eye and adnexa

684

1.44

3.02

1.1

1.54

1.49

g/l

0.71

613

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

198

971

1.30

3.01

1.1

1.42

1.46

g/l

0.71

191

885

Allergic urticaria

370

1.60

3.00

1.1

1.58

1.48

g/l

1.12

333

Carcinoma in situ of skin of upper limb, including shoulder

2.38

3.00

1.1

1.54

1.59

g/l

0.31

Stomatitis and related lesions

135

997

1.36

2.99

1.1

1.49

1.51

g/l

0.23

124

891

Stenosis and insufficiency of lacrimal passages

394

1.58

2.99

1.0

1.1

1.51

1.54

g/l

0.18

361

Pain in thoracic spine

111

794

1.40

2.99

1.1

1.49

1.52

g/l

0.27

101

724

Visual disturbances

340

2815

1.21

2.99

1.1

1.47

1.51

g/l

0.96

310

2553

Laparoscopic left hemicolectomy

2.51

2.98

1.2

1.1

1.58

1.56

g/l

0.11

Cardiac murmurs and other cardiac sounds

351

1.61

2.97

1.1

1.52

1.47

g/l

0.43

316

severe traumatic brain injury, does not include concussion

137

1015

1.35

2.97

1.1

1.56

1.53

g/l

0.40

117

918

Pre-eclampsia or eclampsia

145

1084

1.34

2.97

1.1

1.46

1.49

g/l

0.31

132

980

Benign neoplasm: Adrenal gland

356

1.61

2.96

1.1

1.53

1.52

g/l

0.01

317

Other sleep disorders

507

1.51

2.95

1.1

1.56

1.53

g/l

0.21

457

Tonsillectomy and adenotomy

446

2627

1.18

2.94

1.1

1.42

1.47

g/l

2.18

410

2401

Toxic effects of substances chiefly nonmedicinal as to source

581

1.47

2.93

1.1

1.54

1.50

g/l

0.36

526

Malignant melanoma, including Hilmo

104

738

1.41

2.93

1.1

1.42

1.52

g/l

2.71

647

Amyloidosis, other/unspecified

2.86

2.93

1.1

1.92

1.54

g/l

1.71

Meniscus derangement

416

2357

1.19

2.93

1.1

1.51

g/l

0.09

380

2141

Methotrexate

565

1.47

2.92

1.1

1.56

1.52

g/l

0.55

498

Congenital malformations and deformations of the musculoskeletal system

554

1.48

2.91

1.1

1.49

1.44

g/l

0.42

500

Superficial injury of ankle and foot

623

1.45

2.91

1.1

1.46

1.48

g/l

0.16

564

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS